<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Preoperative evaluation for anesthesia for cardiac surgery</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Preoperative evaluation for anesthesia for cardiac surgery</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Preoperative evaluation for anesthesia for cardiac surgery</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Author:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Atilio Barbeito, MD, MPH</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Jonathan B Mark, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Nancy A Nussmeier, MD, FAHA</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Oct 24, 2022.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1021893858"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Although cardiac surgical techniques and outcomes have improved in the past decade, considerable risks for perioperative morbidity and mortality persist. This topic will review the anesthesiologist's preoperative evaluation of a cardiac surgical patient. This includes assessing cardiac and overall health risks, identifying issues that could cause problems during and after surgery, and working with the cardiologist, cardiac surgeon, or other medical consultants to optimize medical conditions. Examples include stabilizing pulmonary disease with the pulmonology team or assessing risk in a patient with a recent stroke with the neurology team, with planning for surgical timing in such patients. Then an anesthetic care plan is developed, with education of the patient regarding anesthetic care and alleviation of patient anxiety.</p><p>Intraoperative anesthetic management for cardiac surgical procedures (eg, coronary artery bypass grafting [CABG] and cardiac valve surgery) is discussed separately. (See  <a class="medical medical_review" href="/d/html/90607.html" rel="external">"Anesthesia for coronary artery bypass grafting surgery"</a> and  <a class="medical medical_review" href="/d/html/91483.html" rel="external">"Anesthesia for cardiac valve surgery"</a>.)</p><p class="headingAnchor" id="H114618435"><span class="h1">GOALS OF THE PREANESTHESIA EVALUATION</span><span class="headingEndMark"> — </span>During the preoperative consultation, the anesthesiologist will:</p><p class="bulletIndent1"><span class="glyph">●</span>Review the patient's history, physical examination, and available cardiac and other diagnostic tests to assess and minimize risks for the proposed anesthetic and operation. (See <a class="local">'Assessment of patient and procedural risk factors'</a> below.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Explain the proposed anesthetic plan to the patient and obtain informed consent for anesthetic care. Answer all questions related to perioperative anesthetic care.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Alleviate patient anxiety. (See <a class="local">'Alleviation of patient anxiety'</a> below.)</p><p></p><p>If conditions that may be optimized are identified, surgery should be delayed if <strong>all</strong> the following criteria are met: the surgery is elective, the patient's medical condition can be significantly improved, and the risk of postponing surgery is less than the benefit of optimizing the patient's condition. Some older and/or frail patients may benefit from participation in a preoperative prehabilitation program (eg, nutritional supplementation, smoking cessation, physical and cognitive exercise, stress reduction) to improve postoperative functional status and outcomes. Such programs are discussed separately. (See  <a class="medical medical_review" href="/d/html/120301.html" rel="external">"Overview of prehabilitation for surgical patients", section on 'Target patient populations'</a>.)</p><p>Many centers have implemented programs for enhanced recovery after cardiac surgery (ERACS) programs with components in the preoperative, intraoperative, and postoperative periods. Details are discussed separately. (See  <a class="medical medical_review" href="/d/html/126472.html" rel="external">"Anesthetic management for enhanced recovery after cardiac surgery (ERACS)", section on 'Preanesthetic consultation'</a>.)</p><p class="headingAnchor" id="H621846189"><span class="h1">ASSESSMENT OF PATIENT AND PROCEDURAL RISK FACTORS</span><span class="headingEndMark"> — </span>Preoperative assessment of any patient scheduled for surgery must include a comprehensive assessment of both patient and procedural risks, including a detailed history and focused physical examination as well as review of diagnostic studies and preoperative tests. (See  <a class="medical medical_review" href="/d/html/4816.html" rel="external">"Preoperative medical evaluation of the healthy adult patient"</a>.)</p><p class="headingAnchor" id="H114618449"><span class="h2">Cardiovascular risk factors</span><span class="headingEndMark"> — </span>Major cardiovascular conditions affecting risk include myocardial ischemia, ventricular dysfunction with heart failure, and significant atherosclerotic disease of the carotid arteries or the proximal aorta.</p><p class="headingAnchor" id="H114618456"><span class="h3">Myocardial ischemia</span><span class="headingEndMark"> — </span>Patients with severe coronary artery disease requiring surgical revascularization may have low, intermediate, or high risk for cardiovascular complications and mortality. Anesthetic management of these patients is discussed in detail elsewhere. (See  <a class="medical medical_review" href="/d/html/90607.html" rel="external">"Anesthesia for coronary artery bypass grafting surgery"</a>.)</p><p>Factors such as acute myocardial infarction (MI) and degree of hemodynamic stability predict risk and influence urgency for scheduling a surgical intervention, as noted below:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Low risk</strong> – Patients with angina or an anginal equivalent without evidence of a preoperative MI who are scheduled electively have the lowest risk. (See  <a class="medical medical_review" href="/d/html/1579.html" rel="external">"Revascularization in patients with stable coronary artery disease: Coronary artery bypass graft surgery versus percutaneous coronary intervention"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Intermediate risk</strong> – Patients with an acute MI who remain hemodynamically stable have an intermediate risk. These patients are usually hospitalized and may be receiving heparin and antiplatelet medications.</p><p></p><p class="bulletIndent1">If the patient presents within six hours of symptom onset and has multiple coronary lesions, urgent surgical revascularization may maximize myocardial salvage. If the patient presents later than six hours after symptom onset, myocardial necrosis has already reached its peak. In these cases, surgery is usually delayed for three to four days in order to possibly improve operative morbidity and mortality [<a href="#rid1">1,2</a>]. Surgery may be delayed longer (usually five to seven days) if the patient received recent antiplatelet therapy (ie, a P2Y<sub>12</sub> receptor blocking agent). (See <a class="local">'Medications affecting hemostasis'</a> below.)</p><p></p><p class="bulletIndent1">The decision for revascularization, as well as the method and timing of revascularization, are discussed elsewhere. (See  <a class="medical medical_review" href="/d/html/47.html" rel="external">"Coronary artery bypass graft surgery in patients with acute ST-elevation myocardial infarction", section on 'Timing'</a> and  <a class="medical medical_review" href="/d/html/46.html" rel="external">"Non-ST-elevation acute coronary syndromes: Selecting an approach to revascularization"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>High risk</strong> – Patients with an acute MI who are hemodynamically unstable or have another indication for emergency surgical revascularization have a very high risk for morbidity and mortality. Examples include refractory angina despite maximal medical therapy and/or ongoing myocardial ischemia after unsuccessful or complicated percutaneous coronary intervention, cardiogenic shock due to severe left ventricular (LV) or right ventricular (RV) dysfunction, acute severe mitral regurgitation, or rupture of the LV free wall or interventricular septum [<a href="#rid3">3-6</a>]. (See  <a class="medical medical_review" href="/d/html/47.html" rel="external">"Coronary artery bypass graft surgery in patients with acute ST-elevation myocardial infarction", section on 'Indications'</a>.)</p><p></p><p class="bulletIndent1">For patients who have an intraaortic balloon counterpulsation pump (IABP) in place, hemodynamic stability and maximal support of ventricular function and coronary perfusion are achieved by maintaining IABP augmentation at a 1:1 ratio during the preoperative and prebypass periods (see  <a class="medical medical_review" href="/d/html/1482.html" rel="external">"Intraaortic balloon pump counterpulsation"</a>). In a single-center retrospective series, patients who received preoperative IABP support due to rapid worsening hemodynamics had a 17.8 percent 30-day mortality, compared with 5.9 percent for those who received IABP support for unstable angina and 2.7 percent for patients who received IABP support prophylactically [<a href="#rid7">7</a>].</p><p></p><p class="headingAnchor" id="H114618463"><span class="h3">Congestive heart failure</span><span class="headingEndMark"> — </span>Preoperative risk evaluation of patients with congestive heart failure includes assessment of severity of LV and/or RV dysfunction and associated conditions. Knowledge of the following pathology is helpful in designing an anesthetic care plan (eg, selecting monitoring modalities, anesthetic agents, and vasoactive infusions, as well as anticipating a possible need for mechanical support):</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Etiology of ventricular dysfunction</strong> – The etiology of ventricular dysfunction (eg, ischemic cardiomyopathy, severe cardiac valve pathology, diastolic dysfunction) is important to establish perioperative hemodynamic goals.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Degree of left or right ventricular dysfunction</strong> – Patients with severe LV or RV dysfunction may be optimally treated in a tertiary care center offering mechanical circulatory support. LV systolic function is a known predictor of morbidity and mortality in cardiac surgery and is incorporated into most risk prediction models (see <a class="local">'Risk calculators'</a> below). Although RV functional parameters are not incorporated in commonly used risk models, several retrospective and small prospective studies have demonstrated that RV dysfunction is associated with poor outcomes after cardiac surgery [<a href="#rid8">8-11</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Concomitant pulmonary hypertension</strong> – Pulmonary hypertension, defined as mean pulmonary artery pressure (PAP) &gt;20 mmHg at rest, increases morbidity and mortality risk [<a href="#rid11">11-13</a>], and is included in the Parsonnet and EuroSCORE II risk models (see <a class="local">'Risk calculators'</a> below). The severity of pulmonary hypertension is not necessarily commensurate with LV dysfunction (eg, marked pulmonary hypertension may be seen with only mild or moderate LV dysfunction) [<a href="#rid14">14</a>].</p><p></p><p class="headingAnchor" id="H114618470"><span class="h3">Cerebrovascular or proximal aortic atherosclerosis</span><span class="headingEndMark"> — </span>Severe atherosclerosis of the proximal aorta or carotid arteries is a risk factor for perioperative stroke (see  <a class="medical medical_review" href="/d/html/1660.html" rel="external">"Neurologic complications of cardiac surgery"</a>). Other comorbidities (eg, diabetes, hypertension, previous cerebrovascular event, peripheral vascular disease, and smoking-related pulmonary pathology) are typically present.</p><p class="headingAnchor" id="H1036399038"><span class="h4">Carotid artery disease</span><span class="headingEndMark"> — </span>Significant carotid stenosis (ie, &gt;80 percent) is present in 4 to 10 percent of patients undergoing coronary artery bypass grafting (CABG) surgery [<a href="#rid15">15</a>]. Some centers screen for carotid disease in all patients scheduled for coronary surgery (eg, with carotid sonography), while others screen only those at high risk (age &gt;65 years; left main coronary stenosis; peripheral arterial disease; history of transient ischemic attack or stroke, hypertension, tobacco use, or diabetes mellitus) [<a href="#rid16">16-18</a>].</p><p>Uncorrected significant carotid stenosis places the cardiac surgical patient at increased risk for perioperative stroke [<a href="#rid16">16,19-21</a>]. Preoperative strategies to minimize this risk include ensuring that doses of chronically administered <a class="drug drug_general" data-topicid="8907" href="/d/drug information/8907.html" rel="external">aspirin</a>, beta blockers, and statins were received on the morning of surgery. (See  <a class="medical medical_review" href="/d/html/1097.html" rel="external">"Coronary artery bypass grafting in patients with cerebrovascular disease", section on 'Stroke associated with CABG'</a>.)</p><p>Patients with a very high stroke risk may be scheduled for carotid endarterectomy (CEA) prior to or concurrently with their cardiac operation. Concomitant CEA and CABG surgery necessitates coordination between the anesthesiologist and both the vascular and cardiac surgical teams so that everyone understands the planned sequence of procedures. For example, it is necessary to ensure that central venous access is obtained on the side contralateral to the carotid occlusion. (See  <a class="medical medical_review" href="/d/html/1097.html" rel="external">"Coronary artery bypass grafting in patients with cerebrovascular disease", section on 'Prophylactic carotid intervention'</a>.)</p><p>Intraoperative management strategies during cardiopulmonary bypass (CPB) for patients with cerebrovascular disease are discussed separately. (See  <a class="medical medical_review" href="/d/html/130764.html" rel="external">"Management of special populations during cardiac surgery with cardiopulmonary bypass", section on 'Cerebrovascular disease'</a>.)</p><p class="headingAnchor" id="H972386304"><span class="h4">Proximal aortic atherosclerosis or calcification</span><span class="headingEndMark"> — </span>Patients with significant coronary and/or carotid atherosclerotic disease may also have significant atherosclerosis or calcification of the proximal or ascending aorta. Typically, this is evident on chest radiograph (CXR) and/or other imaging studies obtained in the preoperative period (eg, computed tomography [CT] imaging of the chest). During cardiac surgery, thrombi or atheromatous debris can be released from aortic plaques during graft anastomoses, clamping and unclamping of the ascending aorta, or by turbulent high-velocity blood flow delivered via the aortic cannula into a diseased aorta. Since the degree of aortic manipulation has been associated with increased stroke rates [<a href="#rid22">22</a>], the cardiac surgeon may decide to employ off-pump coronary artery bypass grafting in order to avoid cannulation, crossclamping of the atherosclerotic aorta, and the need for CPB.</p><p>In patients with possible or known proximal aortic disease, the cardiac anesthesiologist will plan to perform a thorough intraoperative transesophageal echocardiogram (TEE) assessment for aortic atheromas (see  <a class="medical medical_review" href="/d/html/126473.html" rel="external">"Anesthesia for cardiac surgery: General principles", section on 'Initial transesophageal echocardiography examination'</a>). Contraindications to placement of a TEE probe (eg, dysphagia or odynophagia) are discussed below. (See <a class="local">'Physical examination'</a> below.) </p><p class="headingAnchor" id="H545154316"><span class="h2">Noncardiac risk factors</span><span class="headingEndMark"> — </span>Noncardiac risk factors that cannot be modified include female gender [<a href="#rid23">23,24</a>] and older age [<a href="#rid25">25-27</a>]. (See  <a class="medical medical_review" href="/d/html/14931.html" rel="external">"Anesthesia for the older adult", section on 'Impact of age-related physiologic changes on anesthetic care'</a> and  <a class="medical medical_review" href="/d/html/14931.html" rel="external">"Anesthesia for the older adult", section on 'Preanesthesia consultation'</a>.)</p><p>Potentially modifiable noncardiac risk factors include preexisting renal insufficiency [<a href="#rid28">28-30</a>], anemia that may result in perioperative transfusion [<a href="#rid31">31-33</a>], and current tobacco use. (See  <a class="medical medical_review" href="/d/html/1561.html" rel="external">"Operative mortality after coronary artery bypass graft surgery", section on 'Predictors of risk'</a>.)</p><p class="headingAnchor" id="H2602825226"><span class="h3">Anemia</span><span class="headingEndMark"> — </span>Anemia is common in cardiac surgical patients and has been independently associated with increased risk for red blood cell (RBC) transfusion and adverse outcomes [<a href="#rid34">34-58</a>]. In an observational study that included 1787 women and 2330 men undergoing coronary artery bypass grafting surgery, each 1 g/dL decrease in preoperative hemoglobin &lt;13 g/dL in women was associated with increased risk of RBC transfusion (odds ratio [OR] 2.90, 95% CI 2.33-3.60), acute kidney injury (AKI; OR 1.49, 95% CI 1.23-1.81), reoperation (OR 1.27, 95% CI 1.11-1.45), and longer hospital length of stay (LOS) [<a href="#rid55">55</a>]. For men in this study, each 1 g/dL decrease in preoperative hemoglobin &lt;14 g/dL in was similarly associated with increased risk of RBC transfusion (OR 2.56, 95% CI 2.27-2.88) and longer hospital LOS. RBC transfusion was less likely in women with preoperative hemoglobin &gt;13 g/dL (OR 0.57, 95% CI 0.47-0.69), and less likely in men with preoperative hemoglobin &gt;14 g/dL (OR 0.74, 95% CI 0.60-0.91) [<a href="#rid55">55</a>]. We agree with guidelines developed by the Society of Cardiovascular Anesthesiologists (SCA) [<a href="#rid59">59</a>] and other professional societies [<a href="#rid41">41,45,46,51,60</a>], which state that it is often appropriate to postpone elective cardiac surgery to diagnose causes and ensure correction of preoperative anemia  (<a class="graphic graphic_algorithm graphicRef120496" href="/d/graphic/120496.html" rel="external">algorithm 1</a>), typically defined in this setting as hemoglobin &lt;13 g/dL for women or &lt;14 g/dL for men. (See  <a class="medical medical_review" href="/d/html/94347.html" rel="external">"Perioperative blood management: Strategies to minimize transfusions", section on 'Treatment of anemia'</a> and  <a class="medical medical_review" href="/d/html/1561.html" rel="external">"Operative mortality after coronary artery bypass graft surgery", section on 'Preoperative anemia'</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Iron deficiency anemia </strong>– In a prospective observational study of 730 elective cardiac surgical cases, iron deficiency (defined as ferritin &lt;100 mcg/L) with anemia was associated with an increase in 90-day mortality from 4 to 14 percent (OR 3.5, 95% CI 1.5-8.4). In the same study, patients with iron deficiency without anemia also exhibited increased 90-day mortality from 2 to 5 percent (OR [adjusted for anemia and EuroSCORE comorbidities] 3.2, 95% CI 1.3-7.6) [<a href="#rid61">61</a>]. Iron deficiency has also been associated with a greater number of perioperative transfusions , and with major adverse cardiovascular events (defined as death, acute myocardial infarction, or acute stroke) in cardiac surgical patients [<a href="#rid56">56,61-63</a>].</p><p></p><p class="bulletIndent1">Patients with iron deficiency should be treated with iron rather than transfusion unless anemia is extremely severe with an associated risk of myocardial or other organ ischemia. If iron is administered, sufficient time should be allowed for effective treatment of anemia before surgery (typically two to four weeks for partial correction and six to eight weeks for full correction). In individuals with unexplained iron deficiency, consultation should be obtained to determine the underlying cause (typically with a gastroenterologist to screen for gastrointestinal sources of blood loss or iron malabsorption). (See  <a class="medical medical_review" href="/d/html/7150.html" rel="external">"Causes and diagnosis of iron deficiency and iron deficiency anemia in adults"</a> and  <a class="medical medical_review" href="/d/html/7148.html" rel="external">"Treatment of iron deficiency anemia in adults"</a>.)</p><p></p><p class="bulletIndent1">Oral iron replacement can be initiated in an iron-deficient patient if at least four to six weeks of time is available before planned surgery. Details for therapy are available in a separate topic. (See  <a class="medical medical_review" href="/d/html/7148.html" rel="external">"Treatment of iron deficiency anemia in adults", section on 'Oral iron'</a>.)</p><p></p><p class="bulletIndent1">Intravenous (IV) iron is an option if less time is available in patients with iron-deficiency before semi-elective surgery, and for patients who cannot tolerate oral iron or do not have a response (eg, due to poor absorption). Although IV iron can replenish body iron stores more rapidly and effectively than oral iron therapy, adequate time (ie, one to two weeks for a hemoglobin increase of approximately 1 g/dL) is still required for the iron to be incorporated into developing RBCs to allow the hemoglobin level to increase [<a href="#rid41">41,43,44,50,64-67</a>]. Details for administration of IV iron therapy are available in a separate topic. (See  <a class="medical medical_review" href="/d/html/7148.html" rel="external">"Treatment of iron deficiency anemia in adults", section on 'Oral iron'</a> and  <a class="medical medical_review" href="/d/html/7148.html" rel="external">"Treatment of iron deficiency anemia in adults", section on 'Intravenous iron'</a>.) </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Use of erythropoietin </strong>– Some centers administer erythropoietin (EPO) during the perioperative period in patients undergoing elective cardiac surgical procedures [<a href="#rid48">48,68,69</a>]. In our center, patients are referred preoperatively to our anemia clinic if hemoglobin is &lt;13 g/dL, and these patients typically receive an EPO-stimulating agent (eg, <a class="drug drug_general" data-topicid="9410" href="/d/drug information/9410.html" rel="external">epoetin alfa</a> 600 units/kg weekly, or 300 units/kg daily) for up to 10 days before surgery. Our management is similar to guidelines from the European Association for Cardio-Thoracic Surgery (EACTS) and the European Association of Cardiothoracic Anaesthesiology (EACTA), as well as the 2019 SCA, which suggest that EPO be considered in adults undergoing cardiac surgery who have anemia not due to iron deficiency [<a href="#rid59">59,69</a>]. Also, EPO is often used in patients who do not accept transfusions (eg, Jehovah Witnesses) [<a href="#rid59">59,70,71</a>].</p><p></p><p class="bulletIndent1">Although increased risk of thromboembolic events has been cited as a concern after administration of EPO, patients receiving postoperative anticoagulation are likely to be protected from this risk; other cited complications (eg, hypertension, ischemic events) are unlikely [<a href="#rid51">51,72</a>]. </p><p></p><p class="bulletIndent1">Relevant data regarding benefits and risks of preoperative EPO administration in the cardiac surgical setting are summarized below. Notably, significant heterogeneity with respect to the presence, cause, and severity of preoperative anemia and/or iron deficiency exists in these studies:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>A 2019 meta-analysis of randomized trials comparing preoperative administration of EPO versus placebo (32 trials; 4750 patients, mostly orthopedic and cardiac surgery) found reduced blood transfusions in the EPO groups [<a href="#rid73">73</a>]. Overall, decreased blood transfusions were noted (risk ratio [RR] 0.59, 95% CI 0.47-0.73; 28 trials), and the subgroup of cardiac surgical patients also had fewer transfusions (RR 0.55, 95% CI 0.47-0.73; nine trials; 1520 patients). There was no increase in the incidence of thromboembolic events with EPO.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>A subsequent prospective randomized trial in elective cardiac surgical patients with preoperative <strong>anemia</strong> <strong>or isolated</strong> <strong>iron deficiency</strong> published in 2019 noted reduced RBC transfusions from a median of 1 to 0 units in those who received preoperative treatment with a combination of therapies that included subcutaneous EPO, IV iron, subcutaneous <a class="drug drug_general" data-topicid="9302" href="/d/drug information/9302.html" rel="external">vitamin B12</a>, and oral <a class="drug drug_general" data-topicid="8475" href="/d/drug information/8475.html" rel="external">folic acid</a> on the day before surgery, compared with those receiving placebo drugs (odds ratio [OR] 0.70, 95% CI 0.50-0.98) [<a href="#rid74">74</a>]. However, it is unknown whether administration of IV iron without EPO would have been equally effective in patients with iron deficiency, whether giving vitamin B12 and folate had additional benefits, or whether such approaches to reduce transfusions decrease risk for adverse perioperative events.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Anemia associated with chronic kidney disease </strong>–<strong> </strong>Improvements in degree of anemia in patients with chronic kidney disease (with or without hemodialysis) may be possible with administration of iron and EPO, particularly if some degree of iron deficiency is present. (See  <a class="medical medical_review" href="/d/html/1952.html" rel="external">"Treatment of anemia in nondialysis chronic kidney disease", section on 'Treatment'</a> and  <a class="medical medical_review" href="/d/html/1926.html" rel="external">"Treatment of anemia in patients on dialysis", section on 'Treatment'</a>.) </p><p></p><p class="headingAnchor" id="H486675564"><span class="h3">Red blood cell disorders</span><span class="headingEndMark"> — </span>Disorders of RBCs that have important physiologic consequences for patients undergoing cardiac surgery with cardiopulmonary bypass (CPB) include [<a href="#rid75">75,76</a>]:  </p><p class="bulletIndent1"><span class="glyph">●</span>Cold agglutinin disease (See  <a class="medical medical_review" href="/d/html/7084.html" rel="external">"Cold agglutinin disease"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>Paroxysmal nocturnal hemoglobinuria (See  <a class="medical medical_review" href="/d/html/7163.html" rel="external">"Treatment and prognosis of paroxysmal nocturnal hemoglobinuria", section on 'Surgery'</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>Sickle cell disease (See  <a class="medical medical_review" href="/d/html/90145.html" rel="external">"Red blood cell transfusion in sickle cell disease: Indications and transfusion techniques", section on 'Indications for preoperative transfusion'</a> and  <a class="medical medical_review" href="/d/html/7114.html" rel="external">"Overview of the management and prognosis of sickle cell disease", section on 'Management during hospitalization'</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>Hereditary spherocytosis (See  <a class="medical medical_review" href="/d/html/7079.html" rel="external">"Hereditary spherocytosis"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>Thalassemia) (See  <a class="medical medical_review" href="/d/html/7118.html" rel="external">"Management of thalassemia", section on 'Surgery/anesthesia concerns'</a>.)</p><p></p><p class="headingAnchor" id="H1974395339"><span class="h3">Disorders of hemostasis</span><span class="headingEndMark"> — </span>Perioperative management of patients with inherited or acquired disorders that affect hemostasis is discussed in UpToDate topics for the specific disease. (See  <a class="medical medical_review" href="/d/html/1315.html" rel="external">"Preoperative assessment of bleeding risk"</a> and  <a class="medical medical_review" href="/d/html/94347.html" rel="external">"Perioperative blood management: Strategies to minimize transfusions", section on 'Management of specific hemostatic disorders'</a>.)</p><p class="headingAnchor" id="H1585722477"><span class="h3">Renal insufficiency</span><span class="headingEndMark"> — </span>Patients with preexisting renal insufficiency are at increased risk for developing AKI requiring renal replacement therapy, which occurs in approximately 1 to 2 percent of patients undergoing cardiac surgery [<a href="#rid29">29,77-79</a>]. There is a strong relationship between development of AKI and mortality [<a href="#rid80">80</a>]. Preoperative calculation of the creatinine clearance (CrCl) [<a href="#rid29">29,79,81</a>], or selected cardiac, inflammatory, renal, and metabolic biomarkers [<a href="#rid82">82</a>], may provide a better estimate of renal risk than the serum creatinine (Cr) value. (See  <a class="medical medical_review" href="/d/html/1585.html" rel="external">"Early noncardiac complications of coronary artery bypass graft surgery", section on 'Acute kidney injury'</a> and  <a class="medical medical_review" href="/d/html/1561.html" rel="external">"Operative mortality after coronary artery bypass graft surgery", section on 'Acute kidney injury'</a>.)</p><p>In patients with preexisting renal insufficiency, preoperative attention is directed to any modifiable risk factors. Exposure to nephrotoxic agents is avoided. Volume status is optimized, and any evidence of reduced cardiac output and/or hypotension is promptly treated (see  <a class="medical medical_review" href="/d/html/7224.html" rel="external">"Possible prevention and therapy of ischemic acute tubular necrosis", section on 'Prevention'</a>). Although preoperative anemia is a modifiable risk factor for exacerbation of perioperative renal injury, perioperative RBC transfusions also confer risk [<a href="#rid30">30,34</a>]. (See <a class="local">'Anemia'</a> above.)</p><p>Specific issues concerning the prevention of radiocontrast nephropathy and the prevention of nonischemic causes of acute tubular necrosis are presented in detail elsewhere. (See  <a class="medical medical_review" href="/d/html/7221.html" rel="external">"Prevention of contrast-associated acute kidney injury related to angiography"</a>.)</p><p class="headingAnchor" id="H22383561"><span class="h3">Common comorbid conditions</span><span class="headingEndMark"> — </span>Patients undergoing cardiac surgery typically have one or more comorbid conditions. Details regarding the preoperative evaluation and management of common comorbidities are discussed separately:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Diabetes</strong> – Perioperative goals include avoidance of either hypoglycemia or marked hyperglycemia, as described in detail separately. (See  <a class="medical medical_review" href="/d/html/1753.html" rel="external">"Perioperative management of blood glucose in adults with diabetes mellitus"</a> and  <a class="medical medical_review" href="/d/html/103812.html" rel="external">"Management of cardiopulmonary bypass", section on 'Glucose'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Hypertension</strong> – Chronically administered oral antihypertensive medications should be continued up to the time of surgery. (See  <a class="medical medical_review" href="/d/html/94355.html" rel="external">"Anesthesia for patients with hypertension"</a> and  <a class="medical medical_review" href="/d/html/3868.html" rel="external">"Perioperative management of hypertension"</a>.) </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Chronic obstructive pulmonary disease</strong> – Optimal baseline level of pulmonary function is the major preoperative goal for patients with chronic obstructive pulmonary disease (COPD). Current smokers should be counseled about preoperative cessation. (See  <a class="medical medical_review" href="/d/html/94354.html" rel="external">"Anesthesia for patients with chronic obstructive pulmonary disease", section on 'Preoperative interventions to optimize pulmonary function'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Obstructive sleep apnea </strong>– Obstructive sleep apnea (OSA) is a common sleep disorder with a wide spectrum of severity. One study of more than 500,000 patients undergoing CABG noted that 6.4 percent had a diagnosis of sleep apnea, which was associated with a higher risk for postoperative atrial fibrillation and for hospital readmission within 30 days [<a href="#rid83">83</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Thyroid dysfunction </strong>– Patients with thyroid dysfunction are at increased risk for cardiovascular comorbidities. These include atrial fibrillation, heart failure, pulmonary hypertension, or angina-like symptoms with hyperthyroidism, or reduced heart rate and contractility or hypertension with hypothyroidism. Although it is unknown whether hyperthyroidism or hypothyroidism predispose to perioperative cardiovascular complications, endocrinologic consultation should be considered in patients with suspected thyroid dysfunction or subclinical abnormalities of thyroid stimulating hormone (TSH) level [<a href="#rid84">84</a>]. (See  <a class="medical medical_review" href="/d/html/7853.html" rel="external">"Cardiovascular effects of hyperthyroidism"</a> and  <a class="medical medical_review" href="/d/html/7846.html" rel="external">"Clinical manifestations of hypothyroidism", section on 'Cardiovascular system'</a>.) </p><p></p><p class="headingAnchor" id="H22383797"><span class="h2">Surgical risk factors</span><span class="headingEndMark"> — </span>Emergency cardiac surgery confers a high risk for morbidity and mortality [<a href="#rid16">16,85-87</a>]. (See <a class="local">'Emergency surgery'</a> below.)</p><p>In elective surgery, complexity of the procedure confers additional risk (eg, previous cardiac surgery [<a href="#rid88">88,89</a>], need for combined procedures such as CABG plus cardiac valve surgery [<a href="#rid90">90,91</a>], prolonged duration of aortic crossclamping and/or total CPB time [<a href="#rid92">92</a>]).</p><p>Risk for mortality is also related to the procedural volume (ie, experience) of both the hospital and the individual cardiac surgeon [<a href="#rid93">93-95</a>]. (See  <a class="medical medical_review" href="/d/html/1561.html" rel="external">"Operative mortality after coronary artery bypass graft surgery", section on 'Hospital and surgeon experience'</a>.)</p><p class="headingAnchor" id="H621846314"><span class="h2">Risk calculators</span><span class="headingEndMark"> — </span>Several risk prediction models incorporate patient and procedural characteristics to estimate overall risk of operative mortality, including the EuroSCORE  (<a class="graphic graphic_table graphicRef82521" href="/d/graphic/82521.html" rel="external">table 1</a>) [<a href="#rid96">96</a>], the Society of Thoracic Surgeons [STS] risk calculator, and others [<a href="#rid85">85,86,97-99</a>]. Risk is more difficult to predict in patients who have multiple severe comorbidities and when uncommon procedures are planned. Models for risk prediction are reviewed in detail elsewhere. (See  <a class="medical medical_review" href="/d/html/1561.html" rel="external">"Operative mortality after coronary artery bypass graft surgery", section on 'Risk prediction algorithms'</a>.)</p><p class="headingAnchor" id="H545157463"><span class="h1">PHYSICAL EXAMINATION</span><span class="headingEndMark"> — </span>Physical examination of the patient scheduled for heart surgery should include assessment of:</p><p class="bulletIndent1"><span class="glyph">●</span>Ease and likely adequacy of venous access for both peripheral and central venous catheters. Anticipated difficult venous access may influence selection of the type of intravenous catheter(s) (eg, preoperative placement of a peripherally inserted central catheter [PICC] line, intraoperative placement of a multilumen catheter).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Peripheral arterial pulses in order to determine the best site for invasive arterial pressure monitoring and possible intraaortic balloon pump (IABP) placement.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Abnormalities of the oral cavity and teeth. Severe periodontal disease or other oropharyngeal abnormalities that are potential sources of bacterial infection should be identified and brought to the attention of the surgeon if not already recognized. This is particularly important before any operation that involves implantation of prosthetic material such as an artificial heart valve or synthetic graft material for aneurysm repair.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Integrity of the skin. Cellulitis or untreated ulcers are not uncommon due to the high incidence of diabetic vasculopathy in cardiac surgical patients. These should be brought to the attention of the surgeon if not already recognized.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Predictors of difficulty with airway management. Difficult airway management is planned with particular care in order to avoid hypoxia and hypercarbia, as well as the stress response (with resultant tachycardia and hypertension that will be poorly tolerated in most cardiac surgical patients). (See  <a class="medical medical_review" href="/d/html/90615.html" rel="external">"Management of the difficult airway for general anesthesia in adults", section on 'Planning the anesthetic approach'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Presence of obesity. Obesity confers challenges for anesthetic management, including a higher likelihood of difficulties with airway management and endotracheal intubation, ventilation management, drug dosing, management of pump flow during cardiopulmonary bypass (CPB), and positioning injuries [<a href="#rid100">100</a>]. (See  <a class="medical medical_review" href="/d/html/14932.html" rel="external">"Anesthesia for the patient with obesity"</a>.)</p><p></p><p class="bulletIndent1">Morbid obesity (body mass index [BMI] &gt;40 kg/m<sup>2</sup>) is clearly associated with increased postoperative morbidity, mortality, and cost [<a href="#rid100">100-102</a>]. However, some studies describe an "obesity paradox," in which moderate obesity (BMI 30 to 39 kg/m<sup>2</sup>) confers reduced risk [<a href="#rid100">100,101,103</a>]. Nevertheless, most centers proceed with cardiac surgery in morbidly obese patients if indicated, rather than delaying surgery for counseling and attempted weight loss.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Presence of swallowing problems due to esophageal lesions or problems with neck mobility (eg, due to previous esophageal surgery, dysphagia, or hiatal hernia). This is important because most cardiac procedures and nearly all valve repair or replacement procedures are performed with intraoperative transesophageal echocardiography (TEE) monitoring. Absolute and relative contraindications for placement of a TEE probe are noted in the table  (<a class="graphic graphic_table graphicRef121131" href="/d/graphic/121131.html" rel="external">table 2</a>) . In all cases, the potential benefit from TEE monitoring must be weighed against the relative risk of injury during placement and manipulation of the probe. (See  <a class="medical medical_review" href="/d/html/5320.html" rel="external">"Transesophageal echocardiography: Indications, complications, and normal views", section on 'Safety of TEE examination'</a>.)</p><p></p><p class="headingAnchor" id="H326427779"><span class="h1">PREOPERATIVE TESTS</span></p><p class="headingAnchor" id="H426954906"><span class="h2">Cardiac diagnostic studies</span><span class="headingEndMark"> — </span>Most patients undergoing cardiac surgery have an established diagnosis. Supporting advanced diagnostic studies (eg, cardiac catheterization with coronary arteriography, right heart catheterization, echocardiography, etc) will be available. The anesthesiologist should review this information to gain a clear understanding of the indications for surgery, surgical plan, and individual patient risks in order to appropriately tailor the anesthetic plan.</p><p class="headingAnchor" id="H487128610"><span class="h3">Electrocardiography</span><span class="headingEndMark"> — </span>The electrocardiogram (ECG) is examined for dysrhythmias, conduction abnormalities, myocardial ischemia, and proper functioning of defibrillators or pacemakers in patients with these cardiac implantable electronic devices. (See <a class="local">'Management of implantable cardioverter defibrillators and pacemakers'</a> below.)</p><p class="headingAnchor" id="H487128616"><span class="h3">Echocardiography</span><span class="headingEndMark"> — </span>Preoperative transthoracic echocardiography is routinely performed for patients scheduled to undergo valve repair or replacement, as well as for the majority of patients scheduled to undergo coronary artery bypass grafting (CABG). An exception may be made in patients scheduled for CABG surgery who have no history of valvular heart disease and the left ventricular (LV) function has been quantified by ventriculography during cardiac catheterization. Key echocardiographic findings of importance to the anesthesiologist are described in the table  (<a class="graphic graphic_table graphicRef104169" href="/d/graphic/104169.html" rel="external">table 3</a>).</p><p class="headingAnchor" id="H487128622"><span class="h3">Diagnostic cardiac catheterization</span><span class="headingEndMark"> — </span>Nearly all patients scheduled for either CABG or cardiac valve surgery have undergone recent diagnostic coronary angiography. Typically, right heart catheterization data will also be available in patients with known or suspected left or right ventricular (RV) dysfunction, pulmonary hypertension, or cardiac valve disease. Key cardiac catheterization findings of importance to the anesthesiologist are described in the table  (<a class="graphic graphic_table graphicRef104168" href="/d/graphic/104168.html" rel="external">table 4</a>).</p><p class="headingAnchor" id="H426954900"><span class="h2">Other preoperative tests</span></p><p class="headingAnchor" id="H487128585"><span class="h3">Laboratory tests</span><span class="headingEndMark"> — </span>Blood tests that are routinely available include a complete blood count (CBC), tests of coagulation (prothrombin time, activated partial thromboplastin time, international normalized ratio), and a basic metabolic panel (electrolytes, glucose, creatinine, blood urea nitrogen).</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Anemia</strong> – Anemia noted on the CBC should prompt evaluation for possible reversible causes (see  <a class="medical medical_review" href="/d/html/7133.html" rel="external">"Diagnostic approach to anemia in adults"</a>). If possible, anemia is corrected before surgery (eg, with iron supplementation and/or erythropoietin-stimulating agents) to avoid or minimize transfusion of stored red blood cells (RBCs). (See <a class="local">'Anemia'</a> above and <a class="local">'Pretransfusion testing'</a> below.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Abnormalities in tests of coagulation and platelet count and function</strong> – Abnormalities on tests of coagulation, including platelet count and function should prompt evaluation for reversible causes [<a href="#rid104">104</a>]. Abnormalities due to administration of anticoagulant or antiplatelet agents may necessitate delaying elective surgery or correction for urgent surgery. (See  <a class="medical medical_review" href="/d/html/1315.html" rel="external">"Preoperative assessment of bleeding risk"</a> and <a class="local">'Medications affecting hemostasis'</a> below.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Hyperglycemia</strong> – Hyperglycemia in the preoperative period (ie, blood glucose persistently &gt;180 mg/dL for 12 hours before surgery) in a hospitalized patient is treated by either a continuous intravenous insulin infusion or subcutaneous insulin, depending on the patient's prior use of insulin and the availability of these therapies in the patient's hospital ward [<a href="#rid105">105</a>]. Adequate glycemic control in the perioperative period is associated with reduced mortality, reduced morbidity including wound infections, reduced hospital length of stay (LOS), and improved long-term outcomes [<a href="#rid105">105</a>]. (See  <a class="medical medical_review" href="/d/html/1753.html" rel="external">"Perioperative management of blood glucose in adults with diabetes mellitus"</a> and  <a class="medical medical_review" href="/d/html/1600.html" rel="external">"Glycemic control in critically ill adult and pediatric patients"</a>.)</p><p></p><p>Other major laboratory abnormalities detected during the preoperative assessment should prompt evaluation and management similar to patients undergoing noncardiac surgery. (See  <a class="medical medical_review" href="/d/html/4816.html" rel="external">"Preoperative medical evaluation of the healthy adult patient"</a>.)</p><p class="headingAnchor" id="H22382442"><span class="h3">Pretransfusion testing</span><span class="headingEndMark"> — </span>Typically, at least 2 units of packed RBCs are crossmatched prior to a cardiac surgical procedure since significant blood loss is a possibility in any operation involving the heart and major blood vessels. The anesthesiologist should ensure that these RBC units will be available and determine whether there are issues that may affect the availability of additional crossmatched units (eg, unusual blood type or antibodies). (See  <a class="medical medical_review" href="/d/html/7953.html" rel="external">"Pretransfusion testing for red blood cell transfusion"</a>.)</p><p class="headingAnchor" id="H487128591"><span class="h3">Chest radiograph and computed tomography imaging</span><span class="headingEndMark"> — </span>The preoperative chest radiograph (CXR) often provides necessary anatomic information before cardiac surgery (eg, abnormal heart size or presence of pulmonary edema or pleural effusions indicating congestive heart failure or severe calcification of the thoracic aorta). (See <a class="local">'Congestive heart failure'</a> above and <a class="local">'Proximal aortic atherosclerosis or calcification'</a> above.)</p><p>In patients undergoing repeat cardiac operations via redo sternotomy, the relationship of the aorta and RV free wall to the sternum is noted in the lateral CXR view. Scar adherence of the RV free wall or ascending aorta to the posterior table of the sternum may cause life-threatening hemorrhage due to unintentional right atrial, RV, or aortic injury during sternotomy. Many centers now obtain routine chest computed tomography (CT) scans in redo patients in order to assess the risk of vascular injury during sternotomy, so that alternative cannulation approaches (eg, axillary and femoral) may be planned prior to sternal incision if necessary [<a href="#rid106">106</a>]. (See <a class="local">'Pretransfusion testing'</a> above.)</p><p class="headingAnchor" id="H487128597"><span class="h3">Pulmonary function tests</span><span class="headingEndMark"> — </span>Decisions to obtain preoperative pulmonary function tests (PFTs; eg, spirometry, diffusing capacity for carbon monoxide [DLCO]) and arterial blood gases are guided by individual patient history and physical examination. (See  <a class="medical medical_review" href="/d/html/6917.html" rel="external">"Evaluation of perioperative pulmonary risk", section on 'Preoperative risk assessment'</a>.)</p><p>Moderate or severe airway obstruction, as well as reduced DLCO, on preoperative PFTs confers higher short- and long-term mortality risk in cardiac surgical patients [<a href="#rid107">107,108</a>]. Aside from risk estimation, results of PFTs aid in determining optimal perioperative management strategies (eg, use of inhaled bronchodilators, management of mechanical ventilation, and planning need for prolonged postoperative respiratory support). (See  <a class="medical medical_review" href="/d/html/94354.html" rel="external">"Anesthesia for patients with chronic obstructive pulmonary disease", section on 'Perioperative medication management'</a> and  <a class="medical medical_review" href="/d/html/94354.html" rel="external">"Anesthesia for patients with chronic obstructive pulmonary disease", section on 'Intraoperative management'</a>.)</p><p class="headingAnchor" id="H114618498"><span class="h1">MANAGEMENT OF PREOPERATIVE MEDICATIONS</span></p><p class="headingAnchor" id="H545158053"><span class="h2">Cardiovascular medications</span><span class="headingEndMark"> — </span>Doses of chronically administered cardiovascular medications, particularly beta blockers, are administered on the morning of surgery [<a href="#rid109">109</a>].</p><p>Beta blockers (including <a class="drug drug_general" data-topicid="9941" href="/d/drug information/9941.html" rel="external">sotalol</a>) appear to reduce the incidence of postoperative atrial arrhythmias, and may reduce the incidence of perioperative ventricular arrhythmias [<a href="#rid110">110-113</a>]. A 2019 meta-analysis noted a lower incidence of atrial fibrillation or flutter (risk ratio [RR] 0.50, 95% CI 0.42-0.59; 40 studies, 5660 participants) or ventricular arrhythmias (RR 0.40, 95% CI 0.25-0.63; 122 studies, 2296 participants) in patients receiving perioperative beta blocker therapy compared with those receiving none, although the quality of the evidence was graded as low in this study [<a href="#rid113">113</a>]. (See  <a class="medical medical_review" href="/d/html/1556.html" rel="external">"Coronary artery bypass surgery: Perioperative medical management", section on 'Beta blockers'</a> and  <a class="medical medical_review" href="/d/html/1011.html" rel="external">"Atrial fibrillation and flutter after cardiac surgery", section on 'Prevention of atrial fibrillation and complications'</a>.)</p><p>The majority of patients who present for coronary artery bypass grafting (CABG) surgery have been receiving beta blocker therapy for management of their angina, treatment of hypertension, left ventricular (LV) dysfunction, or secondary prevention after acute myocardial infarction (MI). (See  <a class="medical medical_review" href="/d/html/1466.html" rel="external">"Beta blockers in the management of chronic coronary syndrome", section on 'Summary and recommendations'</a> and  <a class="medical medical_review" href="/d/html/96.html" rel="external">"Acute myocardial infarction: Role of beta blocker therapy", section on 'Summary and recommendations'</a>.)</p><p>Also, most patients referred for CABG will be receiving a statin due to long-term mortality benefits from statin therapy. (See  <a class="medical medical_review" href="/d/html/1556.html" rel="external">"Coronary artery bypass surgery: Perioperative medical management", section on 'Statins'</a>.)</p><p>Recommendations regarding optimal perioperative use of other cardiovascular medications (eg, angiotensin-converting enzyme [ACE] inhibitors, angiotensin II receptor blockers [ARBs], aldosterone antagonists, calcium channel blockers, non-statin hypolipidemic agents, <a class="drug drug_general" data-topicid="9360" href="/d/drug information/9360.html" rel="external">digoxin</a>, and diuretics) are discussed in detail elsewhere. (See  <a class="medical medical_review" href="/d/html/1556.html" rel="external">"Coronary artery bypass surgery: Perioperative medical management", section on 'Angiotensin converting enzyme inhibitors'</a> and  <a class="medical medical_review" href="/d/html/4814.html" rel="external">"Perioperative medication management", section on 'Cardiovascular medications'</a>.) </p><p class="headingAnchor" id="H545158060"><span class="h2">Medications affecting hemostasis</span><span class="headingEndMark"> — </span>Management of preoperative medications that affect hemostasis is important to minimize bleeding risk during cardiac surgery.</p><p class="headingAnchor" id="H2054653735"><span class="h3">Antiplatelet agents</span><span class="headingEndMark"> — </span>Chronic administration of dual antiplatelet therapy with <a class="drug drug_general" data-topicid="8907" href="/d/drug information/8907.html" rel="external">aspirin</a> and P2Y<sub>12</sub> antagonists is common in patients presenting for cardiac surgery, particularly those with coronary artery disease.</p><p class="bulletIndent1"><span class="glyph">●</span><a class="drug drug_general" data-topicid="8907" href="/d/drug information/8907.html" rel="external">Aspirin</a><strong> </strong>– At our center, aspirin is generally continued on the day of surgery, especially for patients who are undergoing coronary revascularization. Chronically administered aspirin is routinely continued in the perioperative period in patients undergoing such procedures due to improved perioperative outcomes (eg, in-hospital mortality, myocardial infarction, stroke) [<a href="#rid114">114-116</a>]. (See  <a class="medical medical_review" href="/d/html/1556.html" rel="external">"Coronary artery bypass surgery: Perioperative medical management", section on 'Aspirin'</a>.)</p><p></p><p class="bulletIndent1"><a class="drug drug_general" data-topicid="8907" href="/d/drug information/8907.html" rel="external">Aspirin</a> administration on the day of surgery is associated with minor increases in perioperative bleeding [<a href="#rid117">117,118</a>], but not with increased risk of mediastinal re-exploration or major transfusion requirements [<a href="#rid119">119-121</a>]. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>P2Y</strong><strong><sub>12</sub></strong><strong> antagonists</strong> – Platelet P2Y<sub>12</sub> receptor inhibitors (eg, <a class="drug drug_general" data-topicid="8921" href="/d/drug information/8921.html" rel="external">clopidogrel</a>, <a class="drug drug_general" data-topicid="9533" href="/d/drug information/9533.html" rel="external">prasugrel</a>, <a class="drug drug_general" data-topicid="16784" href="/d/drug information/16784.html" rel="external">ticagrelor</a>) are usually discontinued five to seven days before elective cardiac surgery due to concerns regarding increased perioperative bleeding, transfusions, and associated adverse outcomes  (<a class="graphic graphic_table graphicRef103236" href="/d/graphic/103236.html" rel="external">table 5</a>) [<a href="#rid122">122,123</a>]. In one study, patients receiving ticagrelor or clopidogrel within two days and three days of coronary artery bypass grafting (CABG) surgery, respectively, had increased risk of severe bleeding [<a href="#rid124">124</a>]. (See  <a class="medical medical_review" href="/d/html/1572.html" rel="external">"Long-term antiplatelet therapy after coronary artery stenting in stable patients"</a> and  <a class="medical medical_review" href="/d/html/1556.html" rel="external">"Coronary artery bypass surgery: Perioperative medical management", section on 'Platelet P2Y12 receptor blocker therapy'</a>.) </p><p></p><p class="bulletIndent1">Patients receiving <a class="drug drug_general" data-topicid="9533" href="/d/drug information/9533.html" rel="external">prasugrel</a> or <a class="drug drug_general" data-topicid="16784" href="/d/drug information/16784.html" rel="external">ticagrelor</a> typically have more potent platelet inhibition than those receiving <a class="drug drug_general" data-topicid="8921" href="/d/drug information/8921.html" rel="external">clopidogrel</a> [<a href="#rid125">125,126</a>]. In some centers, preoperative platelet function testing with a P2Y<sub>12</sub> assay is performed to determine whether residual P2Y<sub>12</sub> antagonist drug effect is present. This information may aid in determining timing of surgery and platelet transfusion strategies pre and intraoperatively. (See  <a class="medical medical_review" href="/d/html/4433.html" rel="external">"Platelet function testing"</a>.) </p><p></p><p class="headingAnchor" id="H4009002181"><span class="h3">Warfarin and direct oral anticoagulants</span><span class="headingEndMark"> — </span>Parenteral or enteral anticoagulant agents (eg, heparins, <a class="drug drug_general" data-topicid="9771" href="/d/drug information/9771.html" rel="external">vitamin K</a> antagonists, direct thrombin inhibitors such as <a class="drug drug_general" data-topicid="8926" href="/d/drug information/8926.html" rel="external">dabigatran</a>, factor Xa inhibitors such as <a class="drug drug_general" data-topicid="9498" href="/d/drug information/9498.html" rel="external">rivaroxaban</a>, <a class="drug drug_general" data-topicid="85642" href="/d/drug information/85642.html" rel="external">apixaban</a>, or <a class="drug drug_general" data-topicid="99275" href="/d/drug information/99275.html" rel="external">edoxaban</a>) should be stopped in sufficient time to allow resolution of anticoagulant effects before elective cardiac surgery. For example, <a class="drug drug_general" data-topicid="10050" href="/d/drug information/10050.html" rel="external">warfarin</a> is typically discontinued five days before elective surgery. The table notes the recommended duration for cessation for direct oral anticoagulants (DOACs) and factor Xa inhibitors  (<a class="graphic graphic_table graphicRef93260" href="/d/graphic/93260.html" rel="external">table 6</a>) [<a href="#rid127">127,128</a>]. However, there is individual variability in resolution of anticoagulant effects, which may take longer in some patients due to factors such as renal insufficiency. Routine laboratory testing can reliably detect residual anticoagulant effect for warfarin (ie, prothrombin time [PT] and international normalized ratio [INR]), but validated and easily accessible tests are not available for all DOACs  (<a class="graphic graphic_table graphicRef91267" href="/d/graphic/91267.html" rel="external">table 7</a>).</p><p>Details regarding management of these agents for elective cardiac surgical procedures and in patients with prosthetic heart valves are available in separate topics:</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/1312.html" rel="external">"Perioperative management of patients receiving anticoagulants"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/104830.html" rel="external">"Anticoagulation for prosthetic heart valves: Management of bleeding and invasive procedures", section on 'Planning for invasive procedures'</a>.)</p><p></p><p>Management of medications affecting hemostasis in patients requiring urgent or emergency surgery is addressed below. (See <a class="local">'Emergency surgery'</a> below.)</p><p class="headingAnchor" id="H640360884"><span class="h2">Other medications</span><span class="headingEndMark"> — </span>Decisions regarding continuation of other chronically administered medications in the perioperative period depend on the medication and patient factors, and are discussed elsewhere. (See  <a class="medical medical_review" href="/d/html/4814.html" rel="external">"Perioperative medication management"</a>.)</p><p class="headingAnchor" id="H389453808"><span class="h1">MANAGEMENT OF IMPLANTABLE CARDIOVERTER DEFIBRILLATORS AND PACEMAKERS</span><span class="headingEndMark"> — </span>Patients undergoing cardiac surgery may have a single- or dual-chamber pacemaker, biventricular pacemaker, and/or implantable cardioverter defibrillator device (ICD) [<a href="#rid129">129</a>]. Considerations for cardiac surgical procedures include:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>ICD</strong> – Since cardiac surgery will occur in the vicinity of the device, electromagnetic interference may inappropriately trigger antitachycardia shocks from an ICD or inhibit needed pacing for bradycardia. Placement of a magnet over the device is usually impractical during cardiac surgery due to its location in the anterior chest wall near the surgical incision. Thus, the device should be reprogrammed to an asynchronous mode. Reprogramming is accomplished in the immediate preoperative period or in the operating room before surgical incision. In emergency situations, a sterile magnet or a magnet encased in a sterile sheath may be used in the surgical field.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Pacemaker</strong> – In the pacemaker-dependent patient, the system is usually reprogrammed to an asynchronous mode (VOO or DOO) before surgical incision. The asynchronous mode will prevent the pacemaker from being unintentionally inhibited resulting in severe bradycardia or asystole. In emergency situations, a sterile magnet placed over the pacemaker will disable all sensing, producing an asynchronous VOO or DOO mode.</p><p></p><p class="bulletIndent1">During surgery, the ischemia/reperfusion injury that occurs during crossclamping of the aorta and cardiopulmonary bypass (CPB) as well as direct trauma to the myocardium will temporarily increase the capture threshold of a pacemaker, which may result in loss of capture. Thus, temporary epicardial pacing wires are routinely inserted during cardiac surgery, even in patients who have a permanent pacemaker that will be reprogrammed in the postoperative period to restore permanent parameters.</p><p></p><p>Additional details regarding perioperative management of ICDs and pacemakers are discussed elsewhere [<a href="#rid130">130,131</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/94293.html" rel="external">"Perioperative management of patients with a pacemaker or implantable cardioverter-defibrillator"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/1013.html" rel="external">"Pacing system malfunction: Evaluation and management", section on 'Electromagnetic interference'</a>.)</p><p></p><p class="headingAnchor" id="H389453499"><span class="h1">ALLEVIATION OF PATIENT ANXIETY</span><span class="headingEndMark"> — </span>Discussions with the patient regarding the risks of the proposed operation (eg, serious morbidity or mortality) versus the expected benefits (eg, symptom relief and/or survival advantage) are typically completed by the patient's cardiologist and cardiac surgeon prior to the preanesthesia consultation. Although patients are often understandably nervous in the immediate preoperative period, a calm and empathetic anesthesiologist may significantly reduce anxiety.</p><p class="headingAnchor" id="H545162746"><span class="h1">SPECIAL SITUATIONS</span></p><p class="headingAnchor" id="H1776293249"><span class="h2">Need for palliative care</span><span class="headingEndMark"> — </span>Planning for postoperative care may include a palliative care consultation in selected high-risk cardiac surgical patients to improve end-of-life experiences for the individual and their families [<a href="#rid132">132</a>]. The aim of these consultations is to provide symptomatic and psychosocial support and to communicate goals of care for a potentially difficult or prolonged recovery. (See  <a class="medical medical_review" href="/d/html/14240.html" rel="external">"Benefits, services, and models of subspecialty palliative care"</a>.)</p><p>In a retrospective study that included more than 95,000 patients undergoing high-risk cardiothoracic, vascular, or other major surgery, families of patients who had died during the postoperative period were more likely to retrospectively rate overall care in the final month of life as excellent if they had received a palliative care consultation compared with families who did not have this consultation (odds ratio [OR] 1.47, 95% CI 1.14-1.88) [<a href="#rid133">133</a>]. Similar positive ratings were noted by families who received end-of-life communication and support. However, in this large study, fewer than six percent of the families of deceased patients had received their consultation in the preoperative period, and only 30 percent had received a palliative care consultation at any point in the perioperative period [<a href="#rid133">133</a>].</p><p>More frequent use of perioperative palliative care may improve end-of-life experiences for high-risk surgical patients and their families. Such consultations also improve provision of symptomatic and psychosocial support and communication regarding goals of care for survivors of high-risk surgery who may have a difficult or prolonged recovery.</p><p class="headingAnchor" id="H1585722569"><span class="h2">Patients on dialysis</span><span class="headingEndMark"> — </span>A functional arteriovenous fistula or other dialysis access site in patients with end-stage renal disease (ESRD) impacts the decision regarding which artery to cannulate for invasive arterial pressure monitoring. During surgery, dialysis access sites must be carefully protected and padded to preserve functionality.</p><p>Preoperative management of dialysis-dependent patients, with particular attention to the presence of hyperkalemia, metabolic acidosis, volume overload, or bleeding diathesis, is discussed in detail elsewhere. (See  <a class="medical medical_review" href="/d/html/94254.html" rel="external">"Anesthesia for dialysis patients", section on 'Preanesthetic management'</a>.)</p><p>If necessary, a hemoconcentrator can be added to the cardiopulmonary bypass (CPB) circuit and utilized to perform ultrafiltration, zero-balance ultrafiltration, or hemodialysis in order to correct hypervolemia, hyperkalemia, metabolic acidosis, and azotemia during CPB [<a href="#rid134">134</a>].</p><p class="headingAnchor" id="H545158924"><span class="h2">Emergency surgery</span><span class="headingEndMark"> — </span>Patients requiring emergency surgery have a high risk for morbidity and mortality [<a href="#rid16">16,85-87</a>]. In this setting, the anesthesiologist may have limited or no time to question the patient directly and/or review the medical record but must nevertheless perform a rapid preoperative evaluation.</p><p class="bulletIndent1"><span class="glyph">●</span><strong>General considerations</strong></p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Assess the cardiac pathophysiology and understand the emergency nature of the proposed procedure, as well as any preoperative interventions (eg, attempted fibrinolysis [thrombolysis]).</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Establish intravenous access adequate for fluid resuscitation and transfusions if not already available, as well as intra-arterial access for continuous monitoring of arterial blood pressure. Other monitors (eg, central venous access and transesophageal echocardiography [TEE]) are typically inserted after induction of anesthesia.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Check availability of blood products. It is prudent to have an adequate number of RBC units typed and crossmatched that will address any existing anemia and anticipated surgical blood loss (see <a class="local">'Pretransfusion testing'</a> above). If massive transfusion is a possibility, preoperative communication with the cardiac surgeon regarding estimates of potential blood loss and subsequent communication with the blood bank are essential.</p><p></p><p class="bulletIndent2">In some emergency situations (eg, rapid bleeding due to aortic dissection), there might not be time to perform full compatibility testing. Decisions regarding transfusion in such settings depend on assessment of the risks and benefits of immediate transfusion versus full blood compatibility testing. Importantly, "emergency release" blood, typically group O, is always available for immediate lifesaving transfusion. (See  <a class="medical medical_review" href="/d/html/7953.html" rel="external">"Pretransfusion testing for red blood cell transfusion", section on 'Emergency release blood for life-threatening anemia or bleeding'</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Briefly speak to the patient, family members, and/or care team members (eg, cardiologist, cardiac surgeon, intensivist, intensive care nurse) to determine:</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>Allergies</p><p class="bulletIndent3"><span class="glyph">-</span>Fasting status</p><p class="bulletIndent3"><span class="glyph">-</span>Relevant past medical and surgical history</p><p class="bulletIndent3"><span class="glyph">-</span>Problems with prior anesthetics</p><p class="bulletIndent3"><span class="glyph">-</span>Recently administered medications (eg, chronically administered antiplatelet and/or anticoagulant agents) (see <a class="local">'Medications affecting hemostasis'</a> above)</p><p class="bulletIndent3"><span class="glyph">-</span>Most recent laboratory results</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Review the patient's chart, if time allows.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Emergency reversal of medication affecting hemostasis </strong>— Management of the ongoing effects of chronically or acutely administered medications affecting hemostasis may be necessary in patients undergoing urgent or emergency cardiac surgery.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Antiplatelet agents</strong> – If discontinuation of P2Y<sub>12</sub> antagonists in patients presenting for urgent cardiac surgery is not possible (eg, those with unstable angina or after unsuccessful percutaneous coronary intervention), bleeding risk is increased [<a href="#rid135">135,136</a>]. Intraoperative administration of platelets (eg, 1 apheresis unit or 6 units of pooled platelets) may be necessary to overcome the effects of recently administered antiplatelet agents in patients with unacceptable microvascular bleeding [<a href="#rid136">136,137</a>]. In these cases, preoperative communication with the blood bank is necessary to ensure platelet availability.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Anticoagulant agents</strong> – If discontinuation of anticoagulant agents is not possible (eg, emergency replacement of a malfunctioning prosthetic valve in a patient chronically receiving anticoagulant agents), then urgent anticoagulant reversal may be necessary. For <a class="drug drug_general" data-topicid="10050" href="/d/drug information/10050.html" rel="external">warfarin</a>, a <a class="drug drug_general" data-topicid="9450" href="/d/drug information/9450.html" rel="external">4-factor prothrombin complex concentrate</a> (PCC) product is the preferred treatment for emergency reversal of anticoagulation with a <a class="drug drug_general" data-topicid="9771" href="/d/drug information/9771.html" rel="external">vitamin K</a> antagonist, rather than reversal with fresh frozen plasma  (<a class="graphic graphic_table graphicRef79151" href="/d/graphic/79151.html" rel="external">table 8</a> and <a class="graphic graphic_table graphicRef89478" href="/d/graphic/89478.html" rel="external">table 9</a>) [<a href="#rid63">63</a>]. Also, concomitant vitamin K is administered together with the PCC since any PCC has a limited duration of action. The DOACs that inhibit thrombin or factor Xa have shorter half-lives than warfarin, but reversal strategies for DOACs for urgent and emergency procedures may be necessary  (<a class="graphic graphic_table graphicRef96230" href="/d/graphic/96230.html" rel="external">table 10</a> and <a class="graphic graphic_table graphicRef112299" href="/d/graphic/112299.html" rel="external">table 11</a>).</p><p></p><p class="bulletIndent2">Details regarding management of these agents for urgent or emergency cardiac surgical procedures are available in separate topics:</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>(See  <a class="medical medical_review" href="/d/html/1312.html" rel="external">"Perioperative management of patients receiving anticoagulants", section on 'Urgent/emergency invasive procedure'</a>.)</p><p class="bulletIndent3"><span class="glyph">-</span>(See  <a class="medical medical_review" href="/d/html/1324.html" rel="external">"Management of warfarin-associated bleeding or supratherapeutic INR"</a>.)</p><p class="bulletIndent3"><span class="glyph">-</span>(See  <a class="medical medical_review" href="/d/html/94788.html" rel="external">"Management of bleeding in patients receiving direct oral anticoagulants"</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Fibrinolytic agents</strong> – In patients undergoing emergency CABG procedures after receiving fibrinolytic (thrombolytic) agents during failed attempts to manage acute ST elevation myocardial infarction (MI), it may be necessary to increase fibrinogen levels with transfusion of cryoprecipitate, plasma, or fibrinogen concentrates in addition to administering an antifibrinolytic agent (eg, <a class="drug drug_general" data-topicid="8561" href="/d/drug information/8561.html" rel="external">aminocaproic acid</a> or <a class="drug drug_general" data-topicid="10011" href="/d/drug information/10011.html" rel="external">tranexamic acid</a>). Discussions regarding management of emergency surgery in such patients are available elsewhere: </p><p></p><p class="bulletIndent3"><span class="glyph">-</span>(See  <a class="medical medical_review" href="/d/html/94297.html" rel="external">"Blood management and anticoagulation for cardiopulmonary bypass", section on 'Antifibrinolytic administration'</a> and  <a class="medical medical_review" href="/d/html/1556.html" rel="external">"Coronary artery bypass surgery: Perioperative medical management", section on 'Antifibrinolytic agents'</a>.)</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>(See  <a class="medical medical_review" href="/d/html/122792.html" rel="external">"Achieving hemostasis after cardiac surgery with cardiopulmonary bypass", section on 'Transfusion of other blood components'</a> and  <a class="medical medical_review" href="/d/html/122792.html" rel="external">"Achieving hemostasis after cardiac surgery with cardiopulmonary bypass", section on 'Clotting factors and hemostatic agents'</a>.)</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>(See  <a class="medical medical_review" href="/d/html/91.html" rel="external">"Diagnosis and management of failed fibrinolysis or threatened reocclusion in acute ST-elevation myocardial infarction", section on 'Patients requiring CABG'</a>.)</p><p></p><p class="headingAnchor" id="H1089434842"><span class="h1">SOCIETY GUIDELINE LINKS</span><span class="headingEndMark"> — </span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See  <a class="medical medical_society_guidelines" href="/d/html/115814.html" rel="external">"Society guideline links: Perioperative cardiovascular evaluation and management"</a>.) </p><p class="headingAnchor" id="H614033282"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Goals of the preanesthesia evaluation</strong> (see <a class="local">'Goals of the preanesthesia evaluation'</a> above):</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Assess risks for the proposed operation and then develop an anesthetic plan to minimize risk  (<a class="graphic graphic_table graphicRef82521" href="/d/graphic/82521.html" rel="external">table 1</a>). (See <a class="local">'Assessment of patient and procedural risk factors'</a> above.)</p><p></p><p class="bulletIndent3"><span class="glyph">-</span><strong>Cardiovascular risk factors </strong>(see <a class="local">'Cardiovascular risk factors'</a> above):</p><p></p><p class="bulletIndent3">Myocardial ischemia (see <a class="local">'Myocardial ischemia'</a> above)</p><p class="bulletIndent3">Congestive heart failure (see <a class="local">'Congestive heart failure'</a> above)</p><p class="bulletIndent3">Cerebrovascular or proximal aortic atherosclerosis (see <a class="local">'Cerebrovascular or proximal aortic atherosclerosis'</a> above)</p><p></p><p class="bulletIndent3"><span class="glyph">-</span><strong>Potentially modifiable noncardiac risk factors</strong> (see <a class="local">'Noncardiac risk factors'</a> above and <a class="local">'Laboratory tests'</a> above):</p><p></p><p class="bulletIndent3">Preexisting renal insufficiency</p><p class="bulletIndent3">Anemia</p><p class="bulletIndent3">Current tobacco use. </p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Ensure optimal patient condition or discuss opportunities to improve condition with the cardiologist and cardiac surgeon.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Explain the proposed anesthetic plan, obtain informed consent for anesthetic care, and alleviate anxiety. (See <a class="local">'Alleviation of patient anxiety'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Physical examination</strong> (see <a class="local">'Physical examination'</a> above):</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Ease of venous access for both peripheral and central venous catheters</p><p class="bulletIndent2"><span class="glyph">•</span>Peripheral arterial pulses for invasive arterial pressure monitoring</p><p class="bulletIndent2"><span class="glyph">•</span>Presence of a functional arteriovenous fistula in patients with end-stage renal disease (ESRD) (see <a class="local">'Patients on dialysis'</a> above)</p><p class="bulletIndent2"><span class="glyph">•</span>Severe periodontal disease that may be a source of bacterial infection</p><p class="bulletIndent2"><span class="glyph">•</span>Cellulitis or untreated ulcers that may be sources of bacterial infection</p><p class="bulletIndent2"><span class="glyph">•</span>Difficult airway, in order to plan for appropriate equipment and techniques to accomplish endotracheal intubation</p><p class="bulletIndent2"><span class="glyph">•</span>Presence of esophageal lesions that may preclude intraoperative use of transesophageal echocardiography (TEE)  (<a class="graphic graphic_table graphicRef121131" href="/d/graphic/121131.html" rel="external">table 2</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Preoperative testing – </strong>The electrocardiogram (ECG) and other available studies including echocardiograms  (<a class="graphic graphic_table graphicRef104169" href="/d/graphic/104169.html" rel="external">table 3</a>), coronary angiogram  (<a class="graphic graphic_table graphicRef104168" href="/d/graphic/104168.html" rel="external">table 4</a>), laboratory tests, chest radiograph (CXR), and pulmonary function tests (PFTs) are reviewed to identify abnormalities that will influence anesthetic management. (See <a class="local">'Preoperative tests'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Preoperative management of medications</strong> (see <a class="local">'Management of preoperative medications'</a> above):</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Cardiovascular medications</strong> <strong>–</strong> Doses of chronically administered beta blockers and statins are administered on the morning of surgery. (See <a class="local">'Cardiovascular medications'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Medications affecting hemostasis</strong> (see <a class="local">'Medications affecting hemostasis'</a> above):</p><p></p><p class="bulletIndent3"><span class="glyph">-</span><a class="drug drug_general" data-topicid="8907" href="/d/drug information/8907.html" rel="external">Aspirin</a> is continued perioperatively in patients already being treated. </p><p></p><p class="bulletIndent3"><span class="glyph">-</span>P2Y<sub>12</sub> receptor blockers (eg, <a class="drug drug_general" data-topicid="8921" href="/d/drug information/8921.html" rel="external">clopidogrel</a>, <a class="drug drug_general" data-topicid="9533" href="/d/drug information/9533.html" rel="external">prasugrel</a>, <a class="drug drug_general" data-topicid="16784" href="/d/drug information/16784.html" rel="external">ticagrelor</a>) are discontinued five to seven days before elective cardiac surgery due to concern regarding increased bleeding and transfusion  (<a class="graphic graphic_table graphicRef103236" href="/d/graphic/103236.html" rel="external">table 5</a>). </p><p></p><p class="bulletIndent3"><span class="glyph">-</span>Oral anticoagulant agents are stopped in sufficient time to allow anticoagulation to resolve  (<a class="graphic graphic_table graphicRef93260" href="/d/graphic/93260.html" rel="external">table 6</a> and <a class="graphic graphic_table graphicRef91267" href="/d/graphic/91267.html" rel="external">table 7</a>). Further details regarding management of these agents for elective cardiac surgical procedures and in patients with prosthetic heart valves are available in separate topics:</p><p></p><p class="bulletIndent3">(See  <a class="medical medical_review" href="/d/html/1312.html" rel="external">"Perioperative management of patients receiving anticoagulants"</a>.)</p><p></p><p class="bulletIndent3">(See  <a class="medical medical_review" href="/d/html/104830.html" rel="external">"Anticoagulation for prosthetic heart valves: Management of bleeding and invasive procedures", section on 'Planning for invasive procedures'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Management of implantable cardioverter defibrillators (ICDs) – </strong>Cardiac surgery causes electromagnetic interference with devices such as ICDs or pacemakers. These devices are reprogrammed to an asynchronous mode in the immediate preoperative period or prior to surgical incision. (See <a class="local">'Management of implantable cardioverter defibrillators and pacemakers'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Emergency cardiac surgery </strong>(see <a class="local">'Emergency surgery'</a> above):</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Rapidly assess cardiac pathophysiology and need for the emergency procedure.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Determine presence of (or establish) intravenous and intra-arterial access.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Briefly speak to the patient, family members, and/or care team members to determine:</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>Allergies</p><p class="bulletIndent3"><span class="glyph">-</span>Fasting status</p><p class="bulletIndent3"><span class="glyph">-</span>Relevant past medical and surgical history</p><p class="bulletIndent3"><span class="glyph">-</span>Problems with prior anesthetics</p><p class="bulletIndent3"><span class="glyph">-</span>Recently administered medications, including chronically administered antiplatelet, anticoagulant, and fibrinolytic agents</p><p class="bulletIndent3"><span class="glyph">-</span>Most recent laboratory results</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Check availability of blood products.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>If necessary, plan for reversal of recently administered anticoagulant agents  (<a class="graphic graphic_table graphicRef79151" href="/d/graphic/79151.html" rel="external">table 8</a> and <a class="graphic graphic_table graphicRef89478" href="/d/graphic/89478.html" rel="external">table 9</a> and <a class="graphic graphic_table graphicRef96230" href="/d/graphic/96230.html" rel="external">table 10</a> and <a class="graphic graphic_table graphicRef112299" href="/d/graphic/112299.html" rel="external">table 11</a>), or intraoperative administration of platelets. If fibrinolytic agents were administered, it may be necessary to increase fibrinogen levels with transfusion of cryoprecipitate, plasma, or fibrinogen concentrates in addition to administering an antifibrinolytic agent (eg, <a class="drug drug_general" data-topicid="8561" href="/d/drug information/8561.html" rel="external">aminocaproic acid</a> or <a class="drug drug_general" data-topicid="10011" href="/d/drug information/10011.html" rel="external">tranexamic acid</a>). </p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Review the patient's chart as time allows.</p><p></p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Gu YL, van der Horst IC, Douglas YL, et al. Role of coronary artery bypass grafting during the acute and subacute phase of ST-elevation myocardial infarction. Neth Heart J 2010; 18:348.</a></li><li><a class="nounderline abstract_t">Thielmann M, Neuhäuser M, Marr A, et al. Predictors and outcomes of coronary artery bypass grafting in ST elevation myocardial infarction. Ann Thorac Surg 2007; 84:17.</a></li><li><a class="nounderline abstract_t">Chevalier P, Burri H, Fahrat F, et al. Perioperative outcome and long-term survival of surgery for acute post-infarction mitral regurgitation. Eur J Cardiothorac Surg 2004; 26:330.</a></li><li><a class="nounderline abstract_t">Shamshad F, Kenchaiah S, Finn PV, et al. Fatal myocardial rupture after acute myocardial infarction complicated by heart failure, left ventricular dysfunction, or both: the VALsartan In Acute myocardial iNfarcTion Trial (VALIANT). Am Heart J 2010; 160:145.</a></li><li><a class="nounderline abstract_t">Filizcan U, Kurc E, Cetemen S, et al. Mortality predictors in ST-elevated myocardial infarction patients undergoing coronary artery bypass grafting. Angiology 2011; 62:68.</a></li><li><a class="nounderline abstract_t">Chiu FC, Chang SN, Lin JW, et al. Coronary artery bypass graft surgery provides better survival in patients with acute coronary syndrome or ST-segment elevation myocardial infarction experiencing cardiogenic shock after percutaneous coronary intervention: a propensity score analysis. J Thorac Cardiovasc Surg 2009; 138:1326.</a></li><li><a class="nounderline abstract_t">Gatti G, Morra L, Castaldi G, et al. Preoperative Intra-Aortic Counterpulsation in Cardiac Surgery: Insights From a Retrospective Series of 588 Consecutive High-Risk Patients. J Cardiothorac Vasc Anesth 2018; 32:2077.</a></li><li><a class="nounderline abstract_t">Maslow AD, Regan MM, Panzica P, et al. Precardiopulmonary bypass right ventricular function is associated with poor outcome after coronary artery bypass grafting in patients with severe left ventricular systolic dysfunction. Anesth Analg 2002; 95:1507.</a></li><li><a class="nounderline abstract_t">Haddad F, Denault AY, Couture P, et al. Right ventricular myocardial performance index predicts perioperative mortality or circulatory failure in high-risk valvular surgery. J Am Soc Echocardiogr 2007; 20:1065.</a></li><li><a class="nounderline abstract_t">Ting PC, Wu VC, Liao CC, et al. Preoperative Right Ventricular Dysfunction Indicates High Vasoactive Support Needed After Cardiac Surgery. J Cardiothorac Vasc Anesth 2019; 33:686.</a></li><li><a class="nounderline abstract_t">McGlothlin DP, Granton J, Klepetko W, et al. ISHLT consensus statement: Perioperative management of patients with pulmonary hypertension and right heart failure undergoing surgery. J Heart Lung Transplant 2022; 41:1135.</a></li><li><a class="nounderline abstract_t">Kennedy JL, LaPar DJ, Kern JA, et al. Does the Society of Thoracic Surgeons risk score accurately predict operative mortality for patients with pulmonary hypertension? J Thorac Cardiovasc Surg 2013; 146:631.</a></li><li><a class="nounderline abstract_t">Reich DL, Bodian CA, Krol M, et al. Intraoperative hemodynamic predictors of mortality, stroke, and myocardial infarction after coronary artery bypass surgery. Anesth Analg 1999; 89:814.</a></li><li><a class="nounderline abstract_t">Guazzi M, Galiè N. Pulmonary hypertension in left heart disease. Eur Respir Rev 2012; 21:338.</a></li><li><a class="nounderline abstract_t">Aboyans V, Lacroix P. Indications for carotid screening in patients with coronary artery disease. Presse Med 2009; 38:977.</a></li><li><a class="nounderline abstract_t">Hillis LD, Smith PK, Anderson JL, et al. 2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation 2011; 124:e652.</a></li><li><a class="nounderline abstract_t">Sheiman RG, Janne d'Othée B. Screening carotid sonography before elective coronary artery bypass graft surgery: who needs it. AJR Am J Roentgenol 2007; 188:W475.</a></li><li><a class="nounderline abstract_t">Durand DJ, Perler BA, Roseborough GS, et al. Mandatory versus selective preoperative carotid screening: a retrospective analysis. Ann Thorac Surg 2004; 78:159.</a></li><li><a class="nounderline abstract_t">Prasad SM, Li S, Rankin JS, et al. Current outcomes of simultaneous carotid endarterectomy and coronary artery bypass graft surgery in North America. World J Surg 2010; 34:2292.</a></li><li><a class="nounderline abstract_t">Brott TG, Halperin JL, Abbara S, et al. 2011 ASA/ACCF/AHA/AANN/AANS/ACR/ASNR/CNS/SAIP/SCAI/SIR/SNIS/SVM/SVS guideline on the management of patients with extracranial carotid and vertebral artery disease. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, and the American Stroke Association, American Association of Neuroscience Nurses, American Association of Neurological Surgeons, American College of Radiology, American Society of Neuroradiology, Congress of Neurological Surgeons, Society of Atherosclerosis Imaging and Prevention, Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology, Society of NeuroInterventional Surgery, Society for Vascular Medicine, and Society for Vascular Surgery. Circulation 2011; 124:e54.</a></li><li><a class="nounderline abstract_t">Authors/Task Force members, Windecker S, Kolh P, et al. 2014 ESC/EACTS Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur Heart J 2014; 35:2541.</a></li><li><a class="nounderline abstract_t">Royse AG, Royse CF. Epiaortic ultrasound assessment of the aorta in cardiac surgery. Best Pract Res Clin Anaesthesiol 2009; 23:335.</a></li><li><a class="nounderline abstract_t">Pollock B, Hamman BL, Sass DM, et al. Effect of gender and race on operative mortality after isolated coronary artery bypass grafting. Am J Cardiol 2015; 115:614.</a></li><li><a class="nounderline abstract_t">Saxena A, Dinh D, Smith JA, et al. Sex differences in outcomes following isolated coronary artery bypass graft surgery in Australian patients: analysis of the Australasian Society of Cardiac and Thoracic Surgeons cardiac surgery database. Eur J Cardiothorac Surg 2012; 41:755.</a></li><li><a class="nounderline abstract_t">Scott BH, Seifert FC, Grimson R, Glass PS. Octogenarians undergoing coronary artery bypass graft surgery: resource utilization, postoperative mortality, and morbidity. J Cardiothorac Vasc Anesth 2005; 19:583.</a></li><li><a class="nounderline abstract_t">Johnson WM, Smith JM, Woods SE, et al. Cardiac surgery in octogenarians: does age alone influence outcomes? Arch Surg 2005; 140:1089.</a></li><li><a class="nounderline abstract_t">Baskett R, Buth K, Ghali W, et al. Outcomes in octogenarians undergoing coronary artery bypass grafting. CMAJ 2005; 172:1183.</a></li><li><a class="nounderline abstract_t">Zakeri R, Freemantle N, Barnett V, et al. Relation between mild renal dysfunction and outcomes after coronary artery bypass grafting. Circulation 2005; 112:I270.</a></li><li><a class="nounderline abstract_t">Cooper WA, O'Brien SM, Thourani VH, et al. Impact of renal dysfunction on outcomes of coronary artery bypass surgery: results from the Society of Thoracic Surgeons National Adult Cardiac Database. Circulation 2006; 113:1063.</a></li><li><a class="nounderline abstract_t">Karkouti K, Wijeysundera DN, Yau TM, et al. Acute kidney injury after cardiac surgery: focus on modifiable risk factors. Circulation 2009; 119:495.</a></li><li><a class="nounderline abstract_t">Kulier A, Levin J, Moser R, et al. Impact of preoperative anemia on outcome in patients undergoing coronary artery bypass graft surgery. Circulation 2007; 116:471.</a></li><li><a class="nounderline abstract_t">van Straten AH, Hamad MA, van Zundert AJ, et al. Preoperative hemoglobin level as a predictor of survival after coronary artery bypass grafting: a comparison with the matched general population. Circulation 2009; 120:118.</a></li><li><a class="nounderline abstract_t">Zindrou D, Taylor KM, Bagger JP. Preoperative haemoglobin concentration and mortality rate after coronary artery bypass surgery. Lancet 2002; 359:1747.</a></li><li><a class="nounderline abstract_t">Oprea AD, Del Rio JM, Cooter M, et al. Pre- and postoperative anemia, acute kidney injury, and mortality after coronary artery bypass grafting surgery: a retrospective observational study. Can J Anaesth 2018; 65:46.</a></li><li><a class="nounderline abstract_t">Miceli A, Romeo F, Glauber M, et al. Preoperative anemia increases mortality and postoperative morbidity after cardiac surgery. J Cardiothorac Surg 2014; 9:137.</a></li><li><a class="nounderline abstract_t">Joshi SS, George A, Manasa D, et al. Propensity-matched analysis of association between preoperative anemia and in-hospital mortality in cardiac surgical patients undergoing valvular heart surgeries. Ann Card Anaesth 2015; 18:373.</a></li><li><a class="nounderline abstract_t">Williams ML, He X, Rankin JS, et al. Preoperative hematocrit is a powerful predictor of adverse outcomes in coronary artery bypass graft surgery: a report from the Society of Thoracic Surgeons Adult Cardiac Surgery Database. Ann Thorac Surg 2013; 96:1628.</a></li><li><a class="nounderline abstract_t">Hallward G, Balani N, McCorkell S, et al. The Relationship Between Preoperative Hemoglobin Concentration, Use of Hospital Resources, and Outcomes in Cardiac Surgery. J Cardiothorac Vasc Anesth 2016; 30:901.</a></li><li><a class="nounderline abstract_t">Blaudszun G, Munting KE, Butchart A, et al. The association between borderline pre-operative anaemia in women and outcomes after cardiac surgery: a cohort study. Anaesthesia 2018; 73:572.</a></li><li><a class="nounderline abstract_t">LaPar DJ, Hawkins RB, McMurry TL, et al. Preoperative anemia versus blood transfusion: Which is the culprit for worse outcomes in cardiac surgery? J Thorac Cardiovasc Surg 2018; 156:66.</a></li><li><a class="nounderline abstract_t">Muñoz M, Acheson AG, Auerbach M, et al. International consensus statement on the peri-operative management of anaemia and iron deficiency. Anaesthesia 2017; 72:233.</a></li><li><a class="nounderline abstract_t">Dhir A, Tempe DK. Anemia and Patient Blood Management in Cardiac Surgery-Literature Review and Current Evidence. J Cardiothorac Vasc Anesth 2018; 32:2726.</a></li><li><a class="nounderline abstract_t">Munting KE, Klein AA. Optimisation of pre-operative anaemia in patients before elective major surgery - why, who, when and how? Anaesthesia 2019; 74 Suppl 1:49.</a></li><li><a class="nounderline abstract_t">Steinbicker AU. Role of anesthesiologists in managing perioperative anemia. Curr Opin Anaesthesiol 2019; 32:64.</a></li><li><a class="nounderline abstract_t">American Society of Anesthesiologists Task Force on Perioperative Blood Management. Practice guidelines for perioperative blood management: an updated report by the American Society of Anesthesiologists Task Force on Perioperative Blood Management*. Anesthesiology 2015; 122:241.</a></li><li><a class="nounderline abstract_t">Kotzé A, Harris A, Baker C, et al. British Committee for Standards in Haematology Guidelines on the Identification and Management of Pre-Operative Anaemia. Br J Haematol 2015; 171:322.</a></li><li><a class="nounderline abstract_t">Guinn NR, Guercio JR, Hopkins TJ, et al. How do we develop and implement a preoperative anemia clinic designed to improve perioperative outcomes and reduce cost? Transfusion 2016; 56:297.</a></li><li><a class="nounderline abstract_t">Yanagawa B, Rocha RV, Mazine A, et al. Hemoglobin Optimization for Coronary Bypass: A 10-Year Canadian Multicenter Experience. Ann Thorac Surg 2019; 107:711.</a></li><li><a class="nounderline abstract_t">Lim J, Miles L, Litton E. Intravenous Iron Therapy in Patients Undergoing Cardiovascular Surgery: A Narrative Review. J Cardiothorac Vasc Anesth 2018; 32:1439.</a></li><li><a class="nounderline abstract_t">Muñoz M, Gómez-Ramírez S, Besser M, et al. Current misconceptions in diagnosis and management of iron deficiency. Blood Transfus 2017; 15:422.</a></li><li><a class="nounderline abstract_t">Mueller MM, Van Remoortel H, Meybohm P, et al. Patient Blood Management: Recommendations From the 2018 Frankfurt Consensus Conference. JAMA 2019; 321:983.</a></li><li><a class="nounderline abstract_t">Shander A, Javidroozi M, Ozawa S, Hare GM. What is really dangerous: anaemia or transfusion? Br J Anaesth 2011; 107 Suppl 1:i41.</a></li><li><a class="nounderline abstract_t">Shander A, Javidroozi M. The patient with anemia. Curr Opin Anaesthesiol 2016; 29:438.</a></li><li><a class="nounderline abstract_t">Shander A, Goodnough LT, Javidroozi M, et al. Iron deficiency anemia--bridging the knowledge and practice gap. Transfus Med Rev 2014; 28:156.</a></li><li><a class="nounderline abstract_t">Ripoll JG, Smith MM, Hanson AC, et al. Sex-Specific Associations Between Preoperative Anemia and Postoperative Clinical Outcomes in Patients Undergoing Cardiac Surgery. Anesth Analg 2021; 132:1101.</a></li><li><a class="nounderline abstract_t">Meybohm P, Westphal S, Ravn HB, et al. Perioperative Anemia Management as Part of PBM in Cardiac Surgery - A Narrative Updated Review. J Cardiothorac Vasc Anesth 2020; 34:1060.</a></li><li><a class="nounderline abstract_t">Shander A, Kaufman M, Goodnough LT. How I treat anemia in the perisurgical setting. Blood 2020; 136:814.</a></li><li><a class="nounderline abstract_t">Evans CR, Jones R, Phillips G, et al. Observational study of pre-operative intravenous iron given to anaemic patients before elective cardiac surgery. Anaesthesia 2021; 76:639.</a></li><li><a class="nounderline abstract_t">Raphael J, Mazer CD, Subramani S, et al. Society of Cardiovascular Anesthesiologists Clinical Practice Improvement Advisory for Management of Perioperative Bleeding and Hemostasis in Cardiac Surgery Patients. Anesth Analg 2019; 129:1209.</a></li><li><a class="nounderline abstract_t">Burns CD, Brown JP, Corwin HL, et al. Special Report From the Society for the Advancement of Blood Management: The Choosing Wisely Campaign. Anesth Analg 2019; 129:1381.</a></li><li><a class="nounderline abstract_t">Rössler J, Schoenrath F, Seifert B, et al. Iron deficiency is associated with higher mortality in patients undergoing cardiac surgery: a prospective study. Br J Anaesth 2020; 124:25.</a></li><li><a class="nounderline abstract_t">Hubert M, Gaudriot B, Biedermann S, et al. Impact of Preoperative Iron Deficiency on Blood Transfusion in Elective Cardiac Surgery. J Cardiothorac Vasc Anesth 2019; 33:2141.</a></li><li><a class="nounderline abstract_t">Levy JH, Douketis J, Steiner T, et al. Prothrombin Complex Concentrates for Perioperative Vitamin K Antagonist and Non-vitamin K Anticoagulant Reversal. Anesthesiology 2018; 129:1171.</a></li><li><a class="nounderline abstract_t">Ellermann I, Bueckmann A, Eveslage M, et al. Treating Anemia in the Preanesthesia Assessment Clinic: Results of a Retrospective Evaluation. Anesth Analg 2018; 127:1202.</a></li><li><a class="nounderline abstract_t">Lin DM, Lin ES, Tran MH. Efficacy and safety of erythropoietin and intravenous iron in perioperative blood management: a systematic review. Transfus Med Rev 2013; 27:221.</a></li><li><a class="nounderline abstract_t">Shander A, Muñoz M, Spahn DR. Intravenous iron for severe iron deficiency anaemia. Br J Anaesth 2018; 121:342.</a></li><li><a class="nounderline abstract_t">Biboulet P, Bringuier S, Smilevitch P, et al. Preoperative Epoetin-α with Intravenous or Oral Iron for Major Orthopedic Surgery: A Randomized Controlled Trial. Anesthesiology 2018; 129:710.</a></li><li><a class="nounderline abstract_t">Desai N, Schofield N, Richards T. Perioperative Patient Blood Management to Improve Outcomes. Anesth Analg 2018; 127:1211.</a></li><li><a class="nounderline abstract_t">Pagano D, Milojevic M, Meesters MI, et al. 2017 EACTS/EACTA Guidelines on patient blood management for adult cardiac surgery. Eur J Cardiothorac Surg 2018; 53:79.</a></li><li><a class="nounderline abstract_t">Klein AA, Bailey CR, Charlton A, et al. Association of Anaesthetists: anaesthesia and peri-operative care for Jehovah's Witnesses and patients who refuse blood. Anaesthesia 2019; 74:74.</a></li><li><a class="nounderline abstract_t">Tan GM, Guinn NR, Frank SM, Shander A. Proceedings From the Society for Advancement of Blood Management Annual Meeting 2017: Management Dilemmas of the Surgical Patient-When Blood Is Not an Option. Anesth Analg 2019; 128:144.</a></li><li><a class="nounderline abstract_t">Unger EF, Thompson AM, Blank MJ, Temple R. Erythropoiesis-stimulating agents--time for a reevaluation. N Engl J Med 2010; 362:189.</a></li><li><a class="nounderline abstract_t">Cho BC, Serini J, Zorrilla-Vaca A, et al. Impact of Preoperative Erythropoietin on Allogeneic Blood Transfusions in Surgical Patients: Results From a Systematic Review and Meta-analysis. Anesth Analg 2019; 128:981.</a></li><li><a class="nounderline abstract_t">Spahn DR, Schoenrath F, Spahn GH, et al. Effect of ultra-short-term treatment of patients with iron deficiency or anaemia undergoing cardiac surgery: a prospective randomised trial. Lancet 2019; 393:2201.</a></li><li><a class="nounderline abstract_t">Smith MM, Renew JR, Nelson JA, Barbara DW. Red Blood Cell Disorders: Perioperative Considerations for Patients Undergoing Cardiac Surgery. J Cardiothorac Vasc Anesth 2019; 33:1393.</a></li><li><a class="nounderline abstract_t">Patel PA, Ghadimi K, Coetzee E, et al. Incidental Cold Agglutinins in Cardiac Surgery: Intraoperative Surprises and Team-Based Problem-Solving Strategies During Cardiopulmonary Bypass. J Cardiothorac Vasc Anesth 2017; 31:1109.</a></li><li><a class="nounderline abstract_t">Wijeysundera DN, Karkouti K, Dupuis JY, et al. Derivation and validation of a simplified predictive index for renal replacement therapy after cardiac surgery. JAMA 2007; 297:1801.</a></li><li><a class="nounderline abstract_t">Mehta RH, Grab JD, O'Brien SM, et al. Bedside tool for predicting the risk of postoperative dialysis in patients undergoing cardiac surgery. Circulation 2006; 114:2208.</a></li><li><a class="nounderline abstract_t">Thakar CV, Arrigain S, Worley S, et al. A clinical score to predict acute renal failure after cardiac surgery. J Am Soc Nephrol 2005; 16:162.</a></li><li><a class="nounderline abstract_t">Thakar CV, Worley S, Arrigain S, et al. Influence of renal dysfunction on mortality after cardiac surgery: modifying effect of preoperative renal function. Kidney Int 2005; 67:1112.</a></li><li><a class="nounderline abstract_t">Wijeysundera DN, Karkouti K, Beattie WS, et al. Improving the identification of patients at risk of postoperative renal failure after cardiac surgery. Anesthesiology 2006; 104:65.</a></li><li><a class="nounderline abstract_t">Verwijmeren L, Bosma M, Vernooij LM, et al. Associations Between Preoperative Biomarkers and Cardiac Surgery-Associated Acute Kidney Injury in Elderly Patients: A Cohort Study. Anesth Analg 2021; 133:570.</a></li><li><a class="nounderline abstract_t">Feng TR, White RS, Ma X, et al. The effect of obstructive sleep apnea on readmissions and atrial fibrillation after cardiac surgery. J Clin Anesth 2019; 56:17.</a></li><li><a class="nounderline abstract_t">Davis JD, Kovar AJ. The Cardiovascular Effects of Subclinical Thyroid Dysfunction. J Cardiothorac Vasc Anesth 2020; 34:35.</a></li><li><a class="nounderline abstract_t">O'Brien SM, Shahian DM, Filardo G, et al. The Society of Thoracic Surgeons 2008 cardiac surgery risk models: part 2--isolated valve surgery. Ann Thorac Surg 2009; 88:S23.</a></li><li><a class="nounderline abstract_t">Shahian DM, O'Brien SM, Filardo G, et al. The Society of Thoracic Surgeons 2008 cardiac surgery risk models: part 1--coronary artery bypass grafting surgery. Ann Thorac Surg 2009; 88:S2.</a></li><li><a class="nounderline abstract_t">Edwards FH, Peterson ED, Coombs LP, et al. Prediction of operative mortality after valve replacement surgery. J Am Coll Cardiol 2001; 37:885.</a></li><li><a class="nounderline abstract_t">Biancari F, Onorati F, Faggian G, et al. Determinants of outcome after isolated coronary artery bypass grafting in patients aged ≤50 years (from the Coronary aRtery diseAse in younG adultS study). Am J Cardiol 2014; 113:275.</a></li><li><a class="nounderline abstract_t">Yaku H, Doi K. Redo coronary artery bypass grafting. Gen Thorac Cardiovasc Surg 2014; 62:453.</a></li><li><a class="nounderline abstract_t">Wolman RL, Nussmeier NA, Aggarwal A, et al. Cerebral injury after cardiac surgery: identification of a group at extraordinary risk. Multicenter Study of Perioperative Ischemia Research Group (McSPI) and the Ischemia Research Education Foundation (IREF) Investigators. Stroke 1999; 30:514.</a></li><li><a class="nounderline abstract_t">Habib AM, Dhanji AR, Mansour SA, et al. The EuroSCORE: a neglected measure of medium-term survival following cardiac surgery. Interact Cardiovasc Thorac Surg 2015; 21:427.</a></li><li><a class="nounderline abstract_t">Weisel RD, Nussmeier N, Newman MF, et al. Predictors of contemporary coronary artery bypass grafting outcomes. J Thorac Cardiovasc Surg 2014; 148:2720.</a></li><li><a class="nounderline abstract_t">Patel HJ, Herbert MA, Drake DH, et al. Aortic valve replacement: using a statewide cardiac surgical database identifies a procedural volume hinge point. Ann Thorac Surg 2013; 96:1560.</a></li><li><a class="nounderline abstract_t">LaPar DJ, Ailawadi G, Isbell JM, et al. Mitral valve repair rates correlate with surgeon and institutional experience. J Thorac Cardiovasc Surg 2014; 148:995.</a></li><li><a class="nounderline abstract_t">Peterson ED, Coombs LP, DeLong ER, et al. Procedural volume as a marker of quality for CABG surgery. JAMA 2004; 291:195.</a></li><li><a class="nounderline abstract_t">Nashef SA, Roques F, Sharples LD, et al. EuroSCORE II. Eur J Cardiothorac Surg 2012; 41:734.</a></li><li><a class="nounderline abstract_t">Shahian DM, O'Brien SM, Filardo G, et al. The Society of Thoracic Surgeons 2008 cardiac surgery risk models: part 3--valve plus coronary artery bypass grafting surgery. Ann Thorac Surg 2009; 88:S43.</a></li><li><a class="nounderline abstract_t">Shahian DM, Edwards FH. The Society of Thoracic Surgeons 2008 cardiac surgery risk models: introduction. Ann Thorac Surg 2009; 88:S1.</a></li><li><a class="nounderline abstract_t">Gosling AF, Hammer M, Grabitz S, et al. Development of an Instrument for Preoperative Prediction of Adverse Discharge in Patients Scheduled for Cardiac Surgery. J Cardiothorac Vasc Anesth 2021; 35:482.</a></li><li><a class="nounderline abstract_t">Chacon MM, Cheruku SR, Neuburger PJ, et al. Perioperative Care of the Obese Cardiac Surgical Patient. J Cardiothorac Vasc Anesth 2018; 32:1911.</a></li><li><a class="nounderline abstract_t">Mariscalco G, Wozniak MJ, Dawson AG, et al. Body Mass Index and Mortality Among Adults Undergoing Cardiac Surgery: A Nationwide Study With a Systematic Review and Meta-Analysis. Circulation 2017; 135:850.</a></li><li><a class="nounderline abstract_t">Ghanta RK, LaPar DJ, Zhang Q, et al. Obesity Increases Risk-Adjusted Morbidity, Mortality, and Cost Following Cardiac Surgery. J Am Heart Assoc 2017; 6.</a></li><li><a class="nounderline abstract_t">Burgos LM, Gil Ramírez A, Seoane L, et al. Is the Obesity Paradox in Cardiac Surgery Really a Myth? Effect of Body Mass Index on Early and Late Clinical Outcomes. J Cardiothorac Vasc Anesth 2021; 35:492.</a></li><li><a class="nounderline abstract_t">Mahla E, Tantry US, Schoerghuber M, Gurbel PA. Platelet Function Testing in Patients on Antiplatelet Therapy before Cardiac Surgery. Anesthesiology 2020; 133:1263.</a></li><li><a class="nounderline abstract_t">Lazar HL, McDonnell M, Chipkin SR, et al. The Society of Thoracic Surgeons practice guideline series: Blood glucose management during adult cardiac surgery. Ann Thorac Surg 2009; 87:663.</a></li><li><a class="nounderline abstract_t">Morishita K, Kawaharada N, Fukada J, et al. Three or more median sternotomies for patients with valve disease: role of computed tomography. Ann Thorac Surg 2003; 75:1476.</a></li><li><a class="nounderline abstract_t">Saleh HZ, Mohan K, Shaw M, et al. Impact of chronic obstructive pulmonary disease severity on surgical outcomes in patients undergoing non-emergent coronary artery bypass grafting. Eur J Cardiothorac Surg 2012; 42:108.</a></li><li><a class="nounderline abstract_t">O'Boyle F, Mediratta N, Chalmers J, et al. Long-term survival of patients with pulmonary disease undergoing coronary artery bypass surgery. Eur J Cardiothorac Surg 2013; 43:697.</a></li><li><a class="nounderline abstract_t">Lomivorotov VV, Efremov SM, Abubakirov MN, et al. Perioperative Management of Cardiovascular Medications. J Cardiothorac Vasc Anesth 2018; 32:2289.</a></li><li><a class="nounderline abstract_t">Oprea AD, Lombard FW, Kertai MD. Perioperative β-Adrenergic Blockade in Noncardiac and Cardiac Surgery: A Clinical Update. J Cardiothorac Vasc Anesth 2019; 33:817.</a></li><li><a class="nounderline abstract_t">Muehlschlegel JD, Burrage PS, Ngai JY, et al. Society of Cardiovascular Anesthesiologists/European Association of Cardiothoracic Anaesthetists Practice Advisory for the Management of Perioperative Atrial Fibrillation in Patients Undergoing Cardiac Surgery. Anesth Analg 2019; 128:33.</a></li><li><a class="nounderline abstract_t">O'Brien B, Burrage PS, Ngai JY, et al. Society of Cardiovascular Anesthesiologists/European Association of Cardiothoracic Anaesthetists Practice Advisory for the Management of Perioperative Atrial Fibrillation in Patients Undergoing Cardiac Surgery. J Cardiothorac Vasc Anesth 2019; 33:12.</a></li><li><a class="nounderline abstract_t">Blessberger H, Lewis SR, Pritchard MW, et al. Perioperative beta-blockers for preventing surgery-related mortality and morbidity in adults undergoing cardiac surgery. Cochrane Database Syst Rev 2019; 9:CD013435.</a></li><li><a class="nounderline abstract_t">Dacey LJ, Munoz JJ, Johnson ER, et al. Effect of preoperative aspirin use on mortality in coronary artery bypass grafting patients. Ann Thorac Surg 2000; 70:1986.</a></li><li><a class="nounderline abstract_t">Bybee KA, Powell BD, Valeti U, et al. Preoperative aspirin therapy is associated with improved postoperative outcomes in patients undergoing coronary artery bypass grafting. Circulation 2005; 112:I286.</a></li><li><a class="nounderline abstract_t">Kulik A, Ruel M, Jneid H, et al. Secondary prevention after coronary artery bypass graft surgery: a scientific statement from the American Heart Association. Circulation 2015; 131:927.</a></li><li><a class="nounderline abstract_t">Ferraris VA, Ferraris SP, Joseph O, et al. Aspirin and postoperative bleeding after coronary artery bypass grafting. Ann Surg 2002; 235:820.</a></li><li><a class="nounderline abstract_t">Ferraris VA, Ferraris SP, Lough FC, Berry WR. Preoperative aspirin ingestion increases operative blood loss after coronary artery bypass grafting. Ann Thorac Surg 1988; 45:71.</a></li><li><a class="nounderline abstract_t">Goldhammer JE, Marhefka GD, Daskalakis C, et al. The Effect of Aspirin on Bleeding and Transfusion in Contemporary Cardiac Surgery. PLoS One 2015; 10:e0134670.</a></li><li><a class="nounderline abstract_t">Jacob M, Smedira N, Blackstone E, et al. Effect of timing of chronic preoperative aspirin discontinuation on morbidity and mortality in coronary artery bypass surgery. Circulation 2011; 123:577.</a></li><li><a class="nounderline abstract_t">Myles PS, Smith JA, Forbes A, et al. Stopping vs. Continuing Aspirin before Coronary Artery Surgery. N Engl J Med 2016; 374:728.</a></li><li><a class="nounderline abstract_t">Ferraris VA, Ferraris SP, Moliterno DJ, et al. The Society of Thoracic Surgeons practice guideline series: aspirin and other antiplatelet agents during operative coronary revascularization (executive summary). Ann Thorac Surg 2005; 79:1454.</a></li><li class="breakAll">Antman EM, Anbe DT, Armstrong PW, et al. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction. www.acc.org/qualityandscience/clinical/statements.htm (Accessed on August 24, 2006).</li><li><a class="nounderline abstract_t">Holm M, Biancari F, Khodabandeh S, et al. Bleeding in Patients Treated With Ticagrelor or Clopidogrel Before Coronary Artery Bypass Grafting. Ann Thorac Surg 2019; 107:1690.</a></li><li><a class="nounderline abstract_t">Malm CJ, Hansson EC, Åkesson J, et al. Preoperative platelet function predicts perioperative bleeding complications in ticagrelor-treated cardiac surgery patients: a prospective observational study. Br J Anaesth 2016; 117:309.</a></li><li><a class="nounderline abstract_t">Angiolillo DJ, Rollini F, Storey RF, et al. International Expert Consensus on Switching Platelet P2Y12 Receptor-Inhibiting Therapies. Circulation 2017; 136:1955.</a></li><li><a class="nounderline abstract_t">Levy JH. Discontinuation and Management of Direct-Acting Anticoagulants for Emergency Procedures. Am J Med 2016; 129:S47.</a></li><li><a class="nounderline abstract_t">Erdoes G, Martinez Lopez De Arroyabe B, Bolliger D, et al. International consensus statement on the peri-operative management of direct oral anticoagulants in cardiac surgery. Anaesthesia 2018; 73:1535.</a></li><li><a class="nounderline abstract_t">WRITING COMMITTEE MEMBERS, Yancy CW, Jessup M, et al. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. Circulation 2013; 128:e240.</a></li><li><a class="nounderline abstract_t">American Society of Anesthesiologists. Practice advisory for the perioperative management of patients with cardiac implantable electronic devices: pacemakers and implantable cardioverter-defibrillators: an updated report by the american society of anesthesiologists task force on perioperative management of patients with cardiac implantable electronic devices. Anesthesiology 2011; 114:247.</a></li><li><a class="nounderline abstract_t">Crossley GH, Poole JE, Rozner MA, et al. The Heart Rhythm Society (HRS)/American Society of Anesthesiologists (ASA) Expert Consensus Statement on the perioperative management of patients with implantable defibrillators, pacemakers and arrhythmia monitors: facilities and patient management this document was developed as a joint project with the American Society of Anesthesiologists (ASA), and in collaboration with the American Heart Association (AHA), and the Society of Thoracic Surgeons (STS). Heart Rhythm 2011; 8:1114.</a></li><li><a class="nounderline abstract_t">Crooms RC, Gelfman LP. Palliative Care and End-of-Life Considerations for the Frail Patient. Anesth Analg 2020; 130:1504.</a></li><li><a class="nounderline abstract_t">Yefimova M, Aslakson RA, Yang L, et al. Palliative Care and End-of-Life Outcomes Following High-risk Surgery. JAMA Surg 2020; 155:138.</a></li><li><a class="nounderline abstract_t">Heath M, Barbeito A, Welsby I, et al. Using Zero-Balance Ultrafiltration With Dialysate as a Replacement Solution for Toxin and Eptifibatide Removal on a Dialysis-Dependent Patient During Cardiopulmonary Bypass. J Cardiothorac Vasc Anesth 2016; 30:162.</a></li><li><a class="nounderline abstract_t">Hansson EC, Rexius H, Dellborg M, et al. Coronary artery bypass grafting-related bleeding complications in real-life acute coronary syndrome patients treated with clopidogrel or ticagrelor. Eur J Cardiothorac Surg 2014; 46:699.</a></li><li><a class="nounderline abstract_t">Williams B, Henderson RA, Reformato VS, et al. Hemostasis Management of Patients Undergoing Emergency Cardiac Surgery After Ticagrelor Loading. J Cardiothorac Vasc Anesth 2020; 34:168.</a></li><li><a class="nounderline abstract_t">Kaufman RM, Djulbegovic B, Gernsheimer T, et al. Platelet transfusion: a clinical practice guideline from the AABB. Ann Intern Med 2015; 162:205.</a></li></ol></div><div id="topicVersionRevision">Topic 94291 Version 46.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20730001" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Role of coronary artery bypass grafting during the acute and subacute phase of ST-elevation myocardial infarction.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17588374" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Predictors and outcomes of coronary artery bypass grafting in ST elevation myocardial infarction.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15296892" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Perioperative outcome and long-term survival of surgery for acute post-infarction mitral regurgitation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20598985" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Fatal myocardial rupture after acute myocardial infarction complicated by heart failure, left ventricular dysfunction, or both: the VALsartan In Acute myocardial iNfarcTion Trial (VALIANT).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20462895" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Mortality predictors in ST-elevated myocardial infarction patients undergoing coronary artery bypass grafting.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19660378" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Coronary artery bypass graft surgery provides better survival in patients with acute coronary syndrome or ST-segment elevation myocardial infarction experiencing cardiogenic shock after percutaneous coronary intervention: a propensity score analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29325843" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Preoperative Intra-Aortic Counterpulsation in Cardiac Surgery: Insights From a Retrospective Series of 588 Consecutive High-Risk Patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12456409" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Precardiopulmonary bypass right ventricular function is associated with poor outcome after coronary artery bypass grafting in patients with severe left ventricular systolic dysfunction.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17566702" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Right ventricular myocardial performance index predicts perioperative mortality or circulatory failure in high-risk valvular surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30177476" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Preoperative Right Ventricular Dysfunction Indicates High Vasoactive Support Needed After Cardiac Surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36123001" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : ISHLT consensus statement: Perioperative management of patients with pulmonary hypertension and right heart failure undergoing surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22982034" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Does the Society of Thoracic Surgeons risk score accurately predict operative mortality for patients with pulmonary hypertension?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10512249" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Intraoperative hemodynamic predictors of mortality, stroke, and myocardial infarction after coronary artery bypass surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23204122" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Pulmonary hypertension in left heart disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19376684" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Indications for carotid screening in patients with coronary artery disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22064599" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : 2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17449747" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Screening carotid sonography before elective coronary artery bypass graft surgery: who needs it.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15223422" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Mandatory versus selective preoperative carotid screening: a retrospective analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20645099" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Current outcomes of simultaneous carotid endarterectomy and coronary artery bypass graft surgery in North America.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21282504" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : 2011 ASA/ACCF/AHA/AANN/AANS/ACR/ASNR/CNS/SAIP/SCAI/SIR/SNIS/SVM/SVS guideline on the management of patients with extracranial carotid and vertebral artery disease. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, and the American Stroke Association, American Association of Neuroscience Nurses, American Association of Neurological Surgeons, American College of Radiology, American Society of Neuroradiology, Congress of Neurological Surgeons, Society of Atherosclerosis Imaging and Prevention, Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology, Society of NeuroInterventional Surgery, Society for Vascular Medicine, and Society for Vascular Surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25173339" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : 2014 ESC/EACTS Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19862892" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Epiaortic ultrasound assessment of the aorta in cardiac surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25596952" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Effect of gender and race on operative mortality after isolated coronary artery bypass grafting.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22423056" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Sex differences in outcomes following isolated coronary artery bypass graft surgery in Australian patients: analysis of the Australasian Society of Cardiac and Thoracic Surgeons cardiac surgery database.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16202890" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Octogenarians undergoing coronary artery bypass graft surgery: resource utilization, postoperative mortality, and morbidity.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16301446" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Cardiac surgery in octogenarians: does age alone influence outcomes?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15851711" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Outcomes in octogenarians undergoing coronary artery bypass grafting.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16159830" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Relation between mild renal dysfunction and outcomes after coronary artery bypass grafting.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16490821" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Impact of renal dysfunction on outcomes of coronary artery bypass surgery: results from the Society of Thoracic Surgeons National Adult Cardiac Database.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19153273" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Acute kidney injury after cardiac surgery: focus on modifiable risk factors.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17620512" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Impact of preoperative anemia on outcome in patients undergoing coronary artery bypass graft surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19564556" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Preoperative hemoglobin level as a predictor of survival after coronary artery bypass grafting: a comparison with the matched general population.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12049866" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Preoperative haemoglobin concentration and mortality rate after coronary artery bypass surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29098634" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Pre- and postoperative anemia, acute kidney injury, and mortality after coronary artery bypass grafting surgery: a retrospective observational study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25096231" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Preoperative anemia increases mortality and postoperative morbidity after cardiac surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26139743" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Propensity-matched analysis of association between preoperative anemia and in-hospital mortality in cardiac surgical patients undergoing valvular heart surgeries.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24055236" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Preoperative hematocrit is a powerful predictor of adverse outcomes in coronary artery bypass graft surgery: a report from the Society of Thoracic Surgeons Adult Cardiac Surgery Database.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27236491" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : The Relationship Between Preoperative Hemoglobin Concentration, Use of Hospital Resources, and Outcomes in Cardiac Surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29349775" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : The association between borderline pre-operative anaemia in women and outcomes after cardiac surgery: a cohort study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29706372" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Preoperative anemia versus blood transfusion: Which is the culprit for worse outcomes in cardiac surgery?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27996086" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : International consensus statement on the peri-operative management of anaemia and iron deficiency.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29307702" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Anemia and Patient Blood Management in Cardiac Surgery-Literature Review and Current Evidence.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30604424" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Optimisation of pre-operative anaemia in patients before elective major surgery - why, who, when and how?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30531608" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Role of anesthesiologists in managing perioperative anemia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25545654" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Practice guidelines for perioperative blood management: an updated report by the American Society of Anesthesiologists Task Force on Perioperative Blood Management*.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26343392" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : British Committee for Standards in Haematology Guidelines on the Identification and Management of Pre-Operative Anaemia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26592207" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : How do we develop and implement a preoperative anemia clinic designed to improve perioperative outcomes and reduce cost?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30529670" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : Hemoglobin Optimization for Coronary Bypass: A 10-Year Canadian Multicenter Experience.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29246691" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Intravenous Iron Therapy in Patients Undergoing Cardiovascular Surgery: A Narrative Review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28880842" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : Current misconceptions in diagnosis and management of iron deficiency.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30860564" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : Patient Blood Management: Recommendations From the 2018 Frankfurt Consensus Conference.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22156270" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : What is really dangerous: anaemia or transfusion?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27022816" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : The patient with anemia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24931617" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : Iron deficiency anemia--bridging the knowledge and practice gap.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33543869" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : Sex-Specific Associations Between Preoperative Anemia and Postoperative Clinical Outcomes in Patients Undergoing Cardiac Surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31399306" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : Perioperative Anemia Management as Part of PBM in Cardiac Surgery - A Narrative Updated Review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32556314" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : How I treat anemia in the perisurgical setting.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33512713" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : Observational study of pre-operative intravenous iron given to anaemic patients before elective cardiac surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31613811" id="rid58" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>59 : Society of Cardiovascular Anesthesiologists Clinical Practice Improvement Advisory for Management of Perioperative Bleeding and Hemostasis in Cardiac Surgery Patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31517679" id="rid59" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>60 : Special Report From the Society for the Advancement of Blood Management: The Choosing Wisely Campaign.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31668348" id="rid60" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>61 : Iron deficiency is associated with higher mortality in patients undergoing cardiac surgery: a prospective study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30857851" id="rid61" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>62 : Impact of Preoperative Iron Deficiency on Blood Transfusion in Elective Cardiac Surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30157037" id="rid62" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>63 : Prothrombin Complex Concentrates for Perioperative Vitamin K Antagonist and Non-vitamin K Anticoagulant Reversal.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29944518" id="rid63" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>64 : Treating Anemia in the Preanesthesia Assessment Clinic: Results of a Retrospective Evaluation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24135037" id="rid64" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>65 : Efficacy and safety of erythropoietin and intravenous iron in perioperative blood management: a systematic review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30032871" id="rid65" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>66 : Intravenous iron for severe iron deficiency anaemia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30074935" id="rid66" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>67 : Preoperative Epoetin-αwith Intravenous or Oral Iron for Major Orthopedic Surgery: A Randomized Controlled Trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29064875" id="rid67" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>68 : Perioperative Patient Blood Management to Improve Outcomes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29029100" id="rid68" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>69 : 2017 EACTS/EACTA Guidelines on patient blood management for adult cardiac surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30270470" id="rid69" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>70 : Association of Anaesthetists: anaesthesia and peri-operative care for Jehovah's Witnesses and patients who refuse blood.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29958216" id="rid70" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>71 : Proceedings From the Society for Advancement of Blood Management Annual Meeting 2017: Management Dilemmas of the Surgical Patient-When Blood Is Not an Option.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20054037" id="rid71" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>72 : Erythropoiesis-stimulating agents--time for a reevaluation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30649068" id="rid72" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>73 : Impact of Preoperative Erythropoietin on Allogeneic Blood Transfusions in Surgical Patients: Results From a Systematic Review and Meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31036337" id="rid73" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>74 : Effect of ultra-short-term treatment of patients with iron deficiency or anaemia undergoing cardiac surgery: a prospective randomised trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30201404" id="rid74" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>75 : Red Blood Cell Disorders: Perioperative Considerations for Patients Undergoing Cardiac Surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27624931" id="rid75" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>76 : Incidental Cold Agglutinins in Cardiac Surgery: Intraoperative Surprises and Team-Based Problem-Solving Strategies During Cardiopulmonary Bypass.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17456822" id="rid76" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>77 : Derivation and validation of a simplified predictive index for renal replacement therapy after cardiac surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17088458" id="rid77" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>78 : Bedside tool for predicting the risk of postoperative dialysis in patients undergoing cardiac surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15563569" id="rid78" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>79 : A clinical score to predict acute renal failure after cardiac surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15698452" id="rid79" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>80 : Influence of renal dysfunction on mortality after cardiac surgery: modifying effect of preoperative renal function.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16394692" id="rid80" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>81 : Improving the identification of patients at risk of postoperative renal failure after cardiac surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34153017" id="rid81" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>82 : Associations Between Preoperative Biomarkers and Cardiac Surgery-Associated Acute Kidney Injury in Elderly Patients: A Cohort Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30665015" id="rid82" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>83 : The effect of obstructive sleep apnea on readmissions and atrial fibrillation after cardiac surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31530455" id="rid83" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>84 : The Cardiovascular Effects of Subclinical Thyroid Dysfunction.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19559823" id="rid84" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>85 : The Society of Thoracic Surgeons 2008 cardiac surgery risk models: part 2--isolated valve surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19559822" id="rid85" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>86 : The Society of Thoracic Surgeons 2008 cardiac surgery risk models: part 1--coronary artery bypass grafting surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11693766" id="rid86" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>87 : Prediction of operative mortality after valve replacement surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24161142" id="rid87" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>88 : Determinants of outcome after isolated coronary artery bypass grafting in patients aged≤50 years (from the Coronary aRtery diseAse in younG adultS study).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24906816" id="rid88" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>89 : Redo coronary artery bypass grafting.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10066845" id="rid89" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>90 : Cerebral injury after cardiac surgery: identification of a group at extraordinary risk. Multicenter Study of Perioperative Ischemia Research Group (McSPI) and the Ischemia Research Education Foundation (IREF) Investigators.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26117842" id="rid90" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>91 : The EuroSCORE: a neglected measure of medium-term survival following cardiac surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25218533" id="rid91" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>92 : Predictors of contemporary coronary artery bypass grafting outcomes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23998408" id="rid92" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>93 : Aortic valve replacement: using a statewide cardiac surgical database identifies a procedural volume hinge point.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25048633" id="rid93" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>94 : Mitral valve repair rates correlate with surgeon and institutional experience.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14722145" id="rid94" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>95 : Procedural volume as a marker of quality for CABG surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22378855" id="rid95" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>96 : EuroSCORE II.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19559824" id="rid96" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>97 : The Society of Thoracic Surgeons 2008 cardiac surgery risk models: part 3--valve plus coronary artery bypass grafting surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19559821" id="rid97" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>98 : The Society of Thoracic Surgeons 2008 cardiac surgery risk models: introduction.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32893054" id="rid98" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>99 : Development of an Instrument for Preoperative Prediction of Adverse Discharge in Patients Scheduled for Cardiac Surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29358013" id="rid99" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>100 : Perioperative Care of the Obese Cardiac Surgical Patient.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28034901" id="rid100" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>101 : Body Mass Index and Mortality Among Adults Undergoing Cardiac Surgery: A Nationwide Study With a Systematic Review and Meta-Analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28275064" id="rid101" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>102 : Obesity Increases Risk-Adjusted Morbidity, Mortality, and Cost Following Cardiac Surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32423731" id="rid102" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>103 : Is the Obesity Paradox in Cardiac Surgery Really a Myth? Effect of Body Mass Index on Early and Late Clinical Outcomes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32898227" id="rid103" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>104 : Platelet Function Testing in Patients on Antiplatelet Therapy before Cardiac Surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19161815" id="rid104" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>105 : The Society of Thoracic Surgeons practice guideline series: Blood glucose management during adult cardiac surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12735565" id="rid105" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>106 : Three or more median sternotomies for patients with valve disease: role of computed tomography.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22290913" id="rid106" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>107 : Impact of chronic obstructive pulmonary disease severity on surgical outcomes in patients undergoing non-emergent coronary artery bypass grafting.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23096454" id="rid107" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>108 : Long-term survival of patients with pulmonary disease undergoing coronary artery bypass surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29482937" id="rid108" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>109 : Perioperative Management of Cardiovascular Medications.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29934209" id="rid109" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>110 : Perioperativeβ-Adrenergic Blockade in Noncardiac and Cardiac Surgery: A Clinical Update.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30550473" id="rid110" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>111 : Society of Cardiovascular Anesthesiologists/European Association of Cardiothoracic Anaesthetists Practice Advisory for the Management of Perioperative Atrial Fibrillation in Patients Undergoing Cardiac Surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30591178" id="rid111" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>112 : Society of Cardiovascular Anesthesiologists/European Association of Cardiothoracic Anaesthetists Practice Advisory for the Management of Perioperative Atrial Fibrillation in Patients Undergoing Cardiac Surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31544227" id="rid112" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>113 : Perioperative beta-blockers for preventing surgery-related mortality and morbidity in adults undergoing cardiac surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11156107" id="rid113" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>114 : Effect of preoperative aspirin use on mortality in coronary artery bypass grafting patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16159833" id="rid114" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>115 : Preoperative aspirin therapy is associated with improved postoperative outcomes in patients undergoing coronary artery bypass grafting.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25679302" id="rid115" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>116 : Secondary prevention after coronary artery bypass graft surgery: a scientific statement from the American Heart Association.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12035038" id="rid116" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>117 : Aspirin and postoperative bleeding after coronary artery bypass grafting.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3257376" id="rid117" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>118 : Preoperative aspirin ingestion increases operative blood loss after coronary artery bypass grafting.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26230605" id="rid118" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>119 : The Effect of Aspirin on Bleeding and Transfusion in Contemporary Cardiac Surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21282503" id="rid119" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>120 : Effect of timing of chronic preoperative aspirin discontinuation on morbidity and mortality in coronary artery bypass surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26933848" id="rid120" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>121 : Stopping vs. Continuing Aspirin before Coronary Artery Surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15797109" id="rid121" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>122 : The Society of Thoracic Surgeons practice guideline series: aspirin and other antiplatelet agents during operative coronary revascularization (executive summary).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15797109" id="rid122" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>123 : The Society of Thoracic Surgeons practice guideline series: aspirin and other antiplatelet agents during operative coronary revascularization (executive summary).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30898561" id="rid123" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>124 : Bleeding in Patients Treated With Ticagrelor or Clopidogrel Before Coronary Artery Bypass Grafting.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27543525" id="rid124" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>125 : Preoperative platelet function predicts perioperative bleeding complications in ticagrelor-treated cardiac surgery patients: a prospective observational study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29084738" id="rid125" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>126 : International Expert Consensus on Switching Platelet P2Y12 Receptor-Inhibiting Therapies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27569675" id="rid126" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>127 : Discontinuation and Management of Direct-Acting Anticoagulants for Emergency Procedures.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30259961" id="rid127" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>128 : International consensus statement on the peri-operative management of direct oral anticoagulants in cardiac surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23741058" id="rid128" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>129 : 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21245737" id="rid129" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>130 : Practice advisory for the perioperative management of patients with cardiac implantable electronic devices: pacemakers and implantable cardioverter-defibrillators: an updated report by the american society of anesthesiologists task force on perioperative management of patients with cardiac implantable electronic devices.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21722856" id="rid130" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>131 : The Heart Rhythm Society (HRS)/American Society of Anesthesiologists (ASA) Expert Consensus Statement on the perioperative management of patients with implantable defibrillators, pacemakers and arrhythmia monitors: facilities and patient management this document was developed as a joint project with the American Society of Anesthesiologists (ASA), and in collaboration with the American Heart Association (AHA), and the Society of Thoracic Surgeons (STS).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32384340" id="rid131" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>132 : Palliative Care and End-of-Life Considerations for the Frail Patient.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31895424" id="rid132" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>133 : Palliative Care and End-of-Life Outcomes Following High-risk Surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25857672" id="rid133" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>134 : Using Zero-Balance Ultrafiltration With Dialysate as a Replacement Solution for Toxin and Eptifibatide Removal on a Dialysis-Dependent Patient During Cardiopulmonary Bypass.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24482383" id="rid134" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>135 : Coronary artery bypass grafting-related bleeding complications in real-life acute coronary syndrome patients treated with clopidogrel or ticagrelor.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31375405" id="rid135" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>136 : Hemostasis Management of Patients Undergoing Emergency Cardiac Surgery After Ticagrelor Loading.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25383671" id="rid136" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>137 : Platelet transfusion: a clinical practice guideline from the AABB.</p>
</a>
</div>
</div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
